LATS2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00170 | S43 | Sugiyama | AIP XAP2 | GELPDFQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELI |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15143 | S330 | Sugiyama | ARPC1B ARC41 | ssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTTGM |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43623 | T208 | PSP | SNAI2 SLUG SLUGH | KICGKAFSRPWLLQGHIRTHtGEKPFSCPHCNRAFADRSNL |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60828 | S247 | PSP | PQBP1 NPW38 JM26 | AKTGADttAAGPLFQQRPyPsPGAVLRANAEASRTKQQD__ |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75376 | S2164 | Sugiyama | NCOR1 KIAA1047 | sEPyEPIsPPQVPVVHEKQDsLLLLSQRGAEPAEQRNDARs |
| O75937 | S81 | Sugiyama | DNAJC8 SPF31 HSPC315 HSPC331 | VLQIDPEVTDEEIKKRFRQLsILVHPDKNQDDADRAQKAFE |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95633 | T228 | Sugiyama | FSTL3 FLRG UNQ674/PRO1308 | QELCGNNNVTYISSCHMRQAtCFLGRSIGVRHAGSCAGTPE |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95721 | S204 | Sugiyama | SNAP29 | MSTDAYPKNPHLRAYHQKIDsNLDELsMGLGRLKDIALGMQ |
| O95863 | T203 | SIGNOR|EPSD|PSP | SNAI1 SNAH | GTCGKAFSRPWLLQGHVRTHtGEKPFSCPHCSRAFADRSNL |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00519 | T178 | SIGNOR | ABL1 ABL JTK7 | PGQRSISLRYEGRVyHYRINtASDGKLyVSSESRFNTLAEL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04632 | Y87 | Sugiyama | CAPNS1 CAPN4 CAPNS | sAISEAAAQYNPEPPPPRtHysNIEANEsEEVRQFRRLFAQ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06493 | T14 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | _______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKK |
| P06899 | S39 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | S449 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | ANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKF |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09661 | S212 | Sugiyama | SNRPA1 | KKGGPsPGDVEAIKNAIANAstLAEVERLKGLLQsGQIPGR |
| P09923 | S111 | Sugiyama | ALPI | DRFPYLALSKTYNVDRQVPDsAATATAYLCGVKANFQTIGL |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11908 | T285 | SIGNOR|PSP | PRPS2 | AFEAVVVTNTIPQEDKMKHCtKIQVIDISMILAEAIRRTHN |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P13073 | S72 | Sugiyama | COX4I1 COX4 | VKHLSASQKALKEKEKASWssLsMDEKVELYRIKFKEsFAE |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S126 | Sugiyama | PDIA4 ERP70 ERP72 | NILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILKKG |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P16083 | S80 | Sugiyama | NQO2 NMOR2 | LSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKVREADLVIF |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18615 | S113 | Sugiyama | NELFE RD RDBP | EGKLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLy |
| P18858 | T183 | Sugiyama | LIG1 | sLTEAEVAtEKEGEDGDQPttPPKPLKTSKAEtPtEsVsEP |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S580 | Sugiyama | NCL | PRGsPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARI |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P21333 | S1459 | Sugiyama | FLNA FLN FLN1 | KVPVHDVTDASKVKCsGPGLsPGMVRANLPQsFQVDTSKAG |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23527 | S39 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P24941 | T14 | Sugiyama | CDK2 CDKN2 | _______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKK |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S70 | Sugiyama | EEF1D EF1D | IARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVE |
| P29692 | S74 | Sugiyama | EEF1D EF1D | RENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVENQsL |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P31153 | Y235 | Sugiyama | MAT2A AMS2 MATA2 | LDEMRDALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGP |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31327 | T900 | Sugiyama | CPS1 | KMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKC |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33176 | S717 | Sugiyama | KIF5B KNS KNS1 | VKQAVEQQIQSHRETHQKQIssLRDEVEAKAKLITDLQDQN |
| P33176 | S950 | Sugiyama | KIF5B KNS KNS1 | PAAsPtHPSAIRGGGAFVQNsQPVAVRGGGGKQV_______ |
| P33778 | S39 | Sugiyama | H2BC3 H2BFF HIST1H2BB | ITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKA |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P34932 | T365 | Sugiyama | HSPA4 APG2 HSPH2 | TRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAILsP |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S55 | Sugiyama | RPL4 RPL1 | DIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVAR |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38936 | S146 | EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | QAEGsPGGPGDSQGRKRRQtsMTDFYHsKRRLIFSKRKP__ |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P40855 | S147 | Sugiyama | PEX19 HK33 PXF OK/SW-cl.22 | SCLKETLSGLAKNATDLQNssMsEEELTKAMEGLGMDEGDG |
| P40925 | S153 | Sugiyama | MDH1 MDHA | ANtNCLtAsKSAPSIPKENFsCLtRLDHNRAKAQIALKLGV |
| P41252 | S1047 | Sugiyama | IARS1 IARS | ESHTEFIFTTIKAPLKPYPVsPsDKVLIQEKTQLKGSELEI |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46108 | S41 | Sugiyama | CRK | QEAVALLQGQRHGVFLVRDsstsPGDyVLSVSENSRVSHYI |
| P46108 | Y47 | Sugiyama | CRK | LQGQRHGVFLVRDsstsPGDyVLSVSENSRVSHYIINSSGP |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S109 | GPS6|PSP|Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P46937 | S127 | GPS6|SIGNOR|EPSD|PSP | YAP1 YAP65 | QAstDAGtAGALtPQHVRAHssPAsLQLGAVsPGtLtPtGV |
| P46937 | S164 | GPS6|PSP | YAP1 YAP65 | PtGVVsGPAAtPTAQHLRQssFEIPDDVPLPAGWEMAKTSS |
| P46937 | S397 | GPS6|SIGNOR|Sugiyama | YAP1 YAP65 | MttNssDPFLNsGtyHsRDEstDsGLsMssysVPRtPDDFL |
| P46937 | S61 | GPS6|EPSD|PSP | YAP1 YAP65 | tQAAPQAPPAGHQIVHVRGDsEtDLEALFNAVMNPKtANVP |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | S659 | Sugiyama | NASP | IEELKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsst |
| P49327 | S207 | Sugiyama | FASN FAS | GINVLLKPNTSVQFLRLGMLsPEGtCKAFDtAGNGYCRSEG |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T598 | Sugiyama | FXR2 FMR1L2 | DESRPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRA |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51858 | S165 | Sugiyama | HDGF HMG1L2 | AKEKNEKGALKRRAGDLLEDsPKRPKEAENPEGEEKEAAtL |
| P52948 | S679 | Sugiyama | NUP98 ADAR2 | ytNPIAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRN |
| P52948 | S681 | Sugiyama | NUP98 ADAR2 | NPIAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGL |
| P52948 | S683 | Sugiyama | NUP98 ADAR2 | IAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGLEG |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60891 | S285 | SIGNOR|PSP | PRPS1 | CFEAVVVTNTIPQEDKMKHCsKIQVIDISMILAEAIRRTHN |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61978 | S420 | Sugiyama | HNRNPK HNRPK | GsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITItGt |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S59 | SIGNOR|EPSD|PSP | YWHAG | NEERNLLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKI |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| Q00526 | T14 | Sugiyama | CDK3 CDKN3 | _______MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKK |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q02241 | S716 | EPSD|PSP | KIF23 KNSL5 MKLP1 | AQISNGQQLMSQPQLHRRsNsCssISVASCISEWEQKIPTy |
| Q02241 | S814 | EPSD|PSP | KIF23 KNSL5 MKLP1 | LLFQPDQNAPPIRLRHRRsRsAGDRWVDHKPASNMQTETVM |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q13155 | S48 | Sugiyama | AIMP2 JTV1 PRO0992 | PNVHGRSyGPAPGAGHVQEEsNLsLQALESRQDDILKRLYE |
| Q13873 | S375 | Sugiyama | BMPR2 PPH1 | SMRLTGNRLVRPGEEDNAAIsEVGtIRYMAPEVLEGAVNLR |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | T216 | Sugiyama | EIF3A EIF3S10 KIAA0139 | KLCDNLRMHLsQIQRHHNQstAINLNNPESQsMHLETRLVQ |
| Q14498 | S336 | Sugiyama | RBM39 HCC1 RNPC2 | LAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGR |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14669 | S987 | Sugiyama | TRIP12 KIAA0045 ULF | AAtHAAADLGsPSLQHSRDDsLDLsPQGRLsDVLKRKRLPK |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14697 | S913 | Sugiyama | GANAB G2AN KIAA0088 | VIIGAGKPAAVVLQTKGSPEsRLsFQHDPEtsVLVLRKPGI |
| Q14697 | S924 | Sugiyama | GANAB G2AN KIAA0088 | VLQTKGSPEsRLsFQHDPEtsVLVLRKPGINVASDWSIHLR |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14872 | S152 | SIGNOR|PSP | MTF1 | TKRKEVKRYQCTFEGCPRTYsTAGNLRTHQKTHRGEYTFVC |
| Q14978 | S686 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | KGKSFRHEKTKKKRGsYRGGsIsVQVNsIKFDsE_______ |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15293 | Y115 | Sugiyama | RCN1 RCN | GDGFVttEELKtWIKRVQKRyIFDNVAKVWKDYDRDKDDKI |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16778 | S39 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKA |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3V6T2 | S1172 | Sugiyama | CCDC88A APE GRDN KIAA1212 | LyDSLIKDHEKLELLHERQAsEyESLISKHGTLKSAHKNLE |
| Q4VCS5 | S175 | SIGNOR|EPSD|PSP | AMOT KIAA1071 | GKMHQDEGLRDLKQGHVRSLsERLMQMSLATSGVKAHPPVT |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5T5C0 | S692 | Sugiyama | STXBP5 LLGL3 | YGSNDPYRREPRSPRKsRQPsGAGLCDIsEGtVVPEDRCKS |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q674X7 | S318 | Sugiyama | KAZN C1orf196 KAZ KIAA1026 HRIHFB2003 | PPHPADRQAVRVsPCHSRQPsVISDASAAEGDRsstPSDIN |
| Q6DN03 | S39 | Sugiyama | H2BC20P HIST2H2BC | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6DRA6 | S39 | Sugiyama | H2BC19P HIST2H2BD | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8N122 | S606 | PSP | RPTOR KIAA1303 RAPTOR | QNFDSARWCGVRDSAHEKLYsLLSDPIPEVRCAAVFALGTF |
| Q8N257 | S39 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | VTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKA |
| Q8N684 | S166 | Sugiyama | CPSF7 | PGKVLNGEKVDVRPAtRQNLsQFEAQARKRECVRVPRGGIP |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8ND56 | S368 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EGNADEEDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEE |
| Q8ND56 | S374 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEERRLNAE |
| Q8NHZ8 | T7 | SIGNOR|EPSD|PSP | CDC26 ANAPC12 C9orf17 | ______________MLRRKPtRLELKLDDIEEFENIRKDLE |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96GQ7 | S79 | Sugiyama | DDX27 cPERP-F RHLP HSPC259 PP3241 | EEEEGPIVLGRRQKALGKNRsADFNPDFVFTEKEGTyDGsW |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q99570 | S853 | Sugiyama | PIK3R4 VPS15 | LVKTKQEPDDKRARKHVKQDsNVNEEWKsMFGsLDPPNMPQ |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZF1 | T355 | Sugiyama | OSBPL8 KIAA1451 ORP8 OSBP10 | NDQEHDEsDNEVMGKSEEsDtDtsERQDDsYIEPEPVEPLK |
| Q9C0C2 | S920 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLGTy |
| Q9C0D5 | S1830 | Sugiyama | TANC1 KIAA1728 | IPVHSQENRITKTVSHLyQEsISKQQPHISNEAHRSHLTAA |
| Q9GZV5 | S311 | GPS6|EPSD | WWTR1 TAZ | ItNNssDPFLNGGPyHsREQsTDsGLGLGCySVPTtPEDFL |
| Q9GZV5 | S89 | GPS6|SIGNOR|EPSD|PSP | WWTR1 TAZ | SsGGHPGPRLAGGAQHVRsHssPAsLQLGtGAGAAGsPAQQ |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9NPD3 | S240 | Sugiyama | EXOSC4 RRP41 SKI6 | AARDVHTLLDRVVRQHVREAsILLGD_______________ |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQS7 | S894 | EPSD|PSP | INCENP | PLDLEDIFKKSKPRYHKRtssAVWNsPPLQGARVPssLAYs |
| Q9NR30 | S706 | Sugiyama | DDX21 | PTASVTEIQEKWHDSRRWQLsVATEQPELEGPREGYGGFRG |
| Q9NRM7 | S576 | Sugiyama | LATS2 KPM | KSRKSAKGDKGGKDKKQIQtsPVPVRKNSRDEEKRESRIKS |
| Q9NRM7 | S653 | Sugiyama | LATS2 KPM | KAGLCEAEQEQMRKILYQKEsNYNRLKRAKMDKSMFVKIKT |
| Q9NRM7 | S829 | Sugiyama | LATS2 KPM | DFGLCTGFRWTHNSKYYQKGsHVRQDsMEPsDLWDDVsNCR |
| Q9NRM7 | S835 | PSP|Sugiyama | LATS2 KPM | GFRWTHNSKYYQKGsHVRQDsMEPsDLWDDVsNCRCGDRLK |
| Q9NRM7 | S839 | Sugiyama | LATS2 KPM | THNSKYYQKGsHVRQDsMEPsDLWDDVsNCRCGDRLKTLEQ |
| Q9NRM7 | S846 | Sugiyama | LATS2 KPM | QKGsHVRQDsMEPsDLWDDVsNCRCGDRLKTLEQRARKQHQ |
| Q9NRM7 | T1024 | Sugiyama | LATS2 KPM | PVDEESPWNDASEGSTKAWDtLtsPNNKHPEHAFYEFtFRR |
| Q9NRM7 | T1026 | Sugiyama | LATS2 KPM | DEESPWNDASEGSTKAWDtLtsPNNKHPEHAFYEFtFRRFF |
| Q9NRM7 | Y1051 | Sugiyama | LATS2 KPM | KHPEHAFYEFtFRRFFDDNGyPFRCPKPSGAEASQAESSDL |
| Q9NRM7 | Y694 | Sugiyama | LATS2 KPM | LGIGAFGEVCLACKVDTHALyAMKTLRKKDVLNRNQVAHVK |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NTZ6 | S525 | Sugiyama | RBM12 KIAA0765 HRIHFB2091 | ITKKGMLEKIDMIRKRLQNFsyDQREMILNPEGDVNSAKVC |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UKG9 | S8 | Sugiyama | CROT COT | _____________MENQLAKstEERTFQYQDSLPSLPVPSL |
| Q9UKG9 | T9 | Sugiyama | CROT COT | ____________MENQLAKstEERTFQYQDSLPSLPVPSLE |
| Q9UKV3 | S388 | Sugiyama | ACIN1 ACINUS KIAA0670 | EEEEREIKssQGLKEKsKsPsPPRLtEDRKKAsLVALPEQt |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UPR0 | T584 | Sugiyama | PLCL2 KIAA1092 PLCE2 | KILIKAKKLsSNCSGVEGDVtDEDEGAEMSQRMGKENMEQP |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2J4 | S159 | SIGNOR|EPSD|PSP | AMOTL2 KIAA0989 | GSRRQDEALRELRHGHVRsLsERLLQLsLERNGARAPsHMs |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5U2 | S86 | Sugiyama | TSSC4 | PSPPSGLLPATVQPFHLRGMssTFSQRsRDIFDCLEGAARR |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.352058e-07 | 6.361 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.851150e-06 | 5.733 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.775568e-06 | 5.109 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.206924e-06 | 5.036 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.821653e-06 | 5.008 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.675446e-05 | 4.435 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.688386e-05 | 4.245 | 1 | 1 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.449493e-05 | 4.190 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.194224e-05 | 4.086 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.107864e-04 | 3.956 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.515056e-04 | 3.820 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.723585e-04 | 3.764 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.863203e-04 | 3.730 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.248241e-04 | 3.488 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.731871e-04 | 3.428 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.213937e-04 | 3.375 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.568052e-04 | 3.340 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.061432e-04 | 3.296 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.134384e-04 | 3.290 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.891387e-04 | 3.162 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.891387e-04 | 3.162 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.891387e-04 | 3.162 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.891387e-04 | 3.162 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.332460e-04 | 3.135 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.084047e-04 | 3.092 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.000373e-03 | 3.000 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.000373e-03 | 3.000 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.219529e-03 | 2.914 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.223693e-03 | 2.912 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.283442e-03 | 2.892 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.869596e-03 | 2.728 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.842102e-03 | 2.735 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.980472e-03 | 2.703 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.115359e-03 | 2.675 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.290214e-03 | 2.640 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.427271e-03 | 2.615 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.709129e-03 | 2.567 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.952941e-03 | 2.530 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.952941e-03 | 2.530 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.071083e-03 | 2.513 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.059700e-03 | 2.514 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.176465e-03 | 2.498 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.449210e-03 | 2.462 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.416513e-03 | 2.466 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.567271e-03 | 2.448 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.987385e-03 | 2.399 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.073026e-03 | 2.390 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.280640e-03 | 2.368 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.329089e-03 | 2.364 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.517774e-03 | 2.345 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.113999e-03 | 2.291 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.631533e-03 | 2.249 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.664819e-03 | 2.247 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.048745e-03 | 2.218 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.689277e-03 | 2.175 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.126820e-03 | 2.147 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.806584e-03 | 2.108 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 8.678291e-03 | 2.062 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.506761e-03 | 2.070 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.569329e-03 | 2.067 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.871634e-03 | 2.052 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.804604e-03 | 2.009 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.144561e-02 | 1.941 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.282304e-02 | 1.892 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.286624e-02 | 1.891 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.356607e-02 | 1.868 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.371414e-02 | 1.863 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.392284e-02 | 1.856 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.510328e-02 | 1.821 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.701387e-02 | 1.769 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.710123e-02 | 1.767 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.849016e-02 | 1.733 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.970455e-02 | 1.705 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.970455e-02 | 1.705 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.121010e-02 | 1.673 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.252415e-02 | 1.647 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.380942e-02 | 1.623 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.346345e-02 | 1.630 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.346345e-02 | 1.630 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.275828e-02 | 1.643 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.316138e-02 | 1.635 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.225946e-02 | 1.652 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.516870e-02 | 1.599 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.639035e-02 | 1.579 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.784246e-02 | 1.555 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.137647e-02 | 1.503 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.137647e-02 | 1.503 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.137647e-02 | 1.503 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.137647e-02 | 1.503 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.377029e-02 | 1.471 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.619125e-02 | 1.441 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.619125e-02 | 1.441 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.564231e-02 | 1.448 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.713461e-02 | 1.430 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.739779e-02 | 1.427 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.739779e-02 | 1.427 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.739779e-02 | 1.427 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.897155e-02 | 1.409 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.021819e-02 | 1.396 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.074241e-02 | 1.390 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.593745e-02 | 1.338 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.593745e-02 | 1.338 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.593745e-02 | 1.338 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.861227e-02 | 1.313 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.861227e-02 | 1.313 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.856138e-02 | 1.314 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.856138e-02 | 1.314 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.856138e-02 | 1.314 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.974223e-02 | 1.303 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.332902e-02 | 1.363 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.015664e-02 | 1.300 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.954272e-02 | 1.305 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.965476e-02 | 1.304 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.444801e-02 | 1.352 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.856138e-02 | 1.314 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.899150e-02 | 1.310 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.861227e-02 | 1.313 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.856138e-02 | 1.314 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.204036e-02 | 1.284 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.661866e-02 | 1.247 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.661866e-02 | 1.247 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.661866e-02 | 1.247 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.147823e-02 | 1.211 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.201939e-02 | 1.207 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.860652e-02 | 1.232 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.860652e-02 | 1.232 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.689991e-02 | 1.245 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.970637e-02 | 1.224 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.689991e-02 | 1.245 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.325538e-02 | 1.199 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 6.325538e-02 | 1.199 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.325538e-02 | 1.199 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.325538e-02 | 1.199 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.067061e-01 | 0.972 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.067061e-01 | 0.972 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 7.580568e-02 | 1.120 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 7.580568e-02 | 1.120 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.020316e-01 | 0.695 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.020316e-01 | 0.695 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.020316e-01 | 0.695 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.020316e-01 | 0.695 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.020316e-01 | 0.695 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.020316e-01 | 0.695 | 0 | 0 |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | R-HSA-5619068 | 2.020316e-01 | 0.695 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.020316e-01 | 0.695 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.020316e-01 | 0.695 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.020316e-01 | 0.695 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 8.312771e-02 | 1.080 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.478357e-01 | 0.830 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.478357e-01 | 0.830 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.478357e-01 | 0.830 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.478357e-01 | 0.830 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.871897e-01 | 0.542 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 2.871897e-01 | 0.542 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 2.871897e-01 | 0.542 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.871897e-01 | 0.542 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 2.871897e-01 | 0.542 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.871897e-01 | 0.542 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.871897e-01 | 0.542 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.053050e-01 | 0.978 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 1.875487e-01 | 0.727 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.875487e-01 | 0.727 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.295095e-01 | 0.888 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.094782e-01 | 0.961 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.554494e-01 | 0.808 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.284929e-01 | 0.641 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.284929e-01 | 0.641 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.284929e-01 | 0.641 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 2.284929e-01 | 0.641 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.284929e-01 | 0.641 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.284929e-01 | 0.641 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.284929e-01 | 0.641 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.284929e-01 | 0.641 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.632642e-01 | 0.440 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.632642e-01 | 0.440 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.632642e-01 | 0.440 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.632642e-01 | 0.440 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.632642e-01 | 0.440 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.632642e-01 | 0.440 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.632642e-01 | 0.440 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.632642e-01 | 0.440 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.632642e-01 | 0.440 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.632642e-01 | 0.440 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.632642e-01 | 0.440 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.632642e-01 | 0.440 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.632642e-01 | 0.440 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.632642e-01 | 0.440 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.632642e-01 | 0.440 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.632642e-01 | 0.440 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 3.632642e-01 | 0.440 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.632642e-01 | 0.440 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.283296e-01 | 0.892 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.283296e-01 | 0.892 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.722479e-02 | 1.112 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.828304e-01 | 0.738 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.828304e-01 | 0.738 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.828304e-01 | 0.738 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.828304e-01 | 0.738 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.828304e-01 | 0.738 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 1.063451e-01 | 0.973 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.494225e-02 | 1.187 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.484232e-01 | 0.828 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.484232e-01 | 0.828 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.699538e-01 | 0.569 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.006564e-01 | 0.997 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.113634e-01 | 0.675 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.696315e-01 | 0.770 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.696315e-01 | 0.770 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.381509e-01 | 0.860 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.411770e-02 | 1.026 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.838151e-02 | 1.106 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.744133e-02 | 1.058 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.407715e-01 | 0.618 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.407715e-01 | 0.618 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.407715e-01 | 0.618 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.113554e-01 | 0.507 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.113554e-01 | 0.507 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.113554e-01 | 0.507 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.113554e-01 | 0.507 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.113554e-01 | 0.507 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.113554e-01 | 0.507 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.113554e-01 | 0.507 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.113554e-01 | 0.507 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.113554e-01 | 0.507 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.113554e-01 | 0.507 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.312238e-01 | 0.365 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.312238e-01 | 0.365 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.312238e-01 | 0.365 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.312238e-01 | 0.365 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.312238e-01 | 0.365 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.312238e-01 | 0.365 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.312238e-01 | 0.365 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.312238e-01 | 0.365 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.094672e-02 | 1.092 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.939623e-02 | 1.049 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.148537e-01 | 0.668 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.148537e-01 | 0.668 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.707935e-01 | 0.567 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.707935e-01 | 0.567 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.707935e-01 | 0.567 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.707935e-01 | 0.567 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.707935e-01 | 0.567 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.707935e-01 | 0.567 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.707935e-01 | 0.567 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.707935e-01 | 0.567 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.425170e-01 | 0.846 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.294332e-01 | 0.888 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.731074e-01 | 0.762 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.731074e-01 | 0.762 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.522385e-01 | 0.453 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.522385e-01 | 0.453 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.522385e-01 | 0.453 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.522385e-01 | 0.453 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.177327e-01 | 0.929 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.561900e-01 | 0.806 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.542636e-02 | 1.122 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.896714e-01 | 0.722 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.896714e-01 | 0.722 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.011874e-01 | 0.521 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.011874e-01 | 0.521 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.628981e-01 | 0.580 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.628981e-01 | 0.580 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.068146e-01 | 0.684 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.666181e-01 | 0.778 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.244826e-01 | 0.649 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.244826e-01 | 0.649 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.529438e-01 | 0.597 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.922424e-01 | 0.406 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.922424e-01 | 0.406 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.922424e-01 | 0.406 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 4.919335e-01 | 0.308 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.919335e-01 | 0.308 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.919335e-01 | 0.308 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.919335e-01 | 0.308 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 4.919335e-01 | 0.308 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.919335e-01 | 0.308 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 4.919335e-01 | 0.308 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.919335e-01 | 0.308 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.919335e-01 | 0.308 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.938259e-01 | 0.713 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.256481e-01 | 0.901 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.426193e-01 | 0.615 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.426193e-01 | 0.615 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.324804e-01 | 0.634 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.240541e-02 | 1.084 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.622274e-01 | 0.441 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 3.622274e-01 | 0.441 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.622274e-01 | 0.441 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.622274e-01 | 0.441 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.673468e-01 | 0.776 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.800684e-01 | 0.553 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.310892e-01 | 0.365 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.310892e-01 | 0.365 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.659874e-01 | 0.575 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.172189e-01 | 0.663 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.924960e-01 | 0.406 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.924960e-01 | 0.406 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.301537e-01 | 0.638 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.832163e-01 | 0.548 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.832163e-01 | 0.548 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.832163e-01 | 0.548 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.687282e-01 | 0.571 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.687282e-01 | 0.571 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.687282e-01 | 0.571 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.687282e-01 | 0.571 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.687282e-01 | 0.571 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.928249e-01 | 0.715 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.392091e-01 | 0.470 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.392091e-01 | 0.470 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.186972e-01 | 0.497 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.701137e-01 | 0.568 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.383098e-01 | 0.471 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.612412e-01 | 0.442 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.884648e-01 | 0.411 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 4.223814e-01 | 0.374 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.223814e-01 | 0.374 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.685705e-01 | 0.329 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.685705e-01 | 0.329 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.685705e-01 | 0.329 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.685705e-01 | 0.329 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.685705e-01 | 0.329 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.461663e-01 | 0.263 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.461663e-01 | 0.263 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.703801e-01 | 0.568 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.000036e-01 | 0.523 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.580464e-01 | 0.446 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.336388e-01 | 0.477 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.517478e-01 | 0.345 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.517478e-01 | 0.345 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.104414e-01 | 0.508 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.274316e-01 | 0.485 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.053363e-01 | 0.392 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.855085e-01 | 0.544 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.045352e-01 | 0.297 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.379108e-01 | 0.471 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.905299e-01 | 0.408 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.298435e-01 | 0.482 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.838258e-01 | 0.416 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.838258e-01 | 0.416 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.775028e-01 | 0.423 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.086807e-01 | 0.389 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.501411e-01 | 0.456 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.090422e-01 | 0.388 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.090422e-01 | 0.388 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.012412e-01 | 0.397 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.807864e-01 | 0.419 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.705674e-01 | 0.327 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.871959e-01 | 0.312 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.084786e-01 | 0.294 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.388801e-01 | 0.269 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.388801e-01 | 0.269 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.388801e-01 | 0.269 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.946131e-01 | 0.226 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.946131e-01 | 0.226 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.946131e-01 | 0.226 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.946131e-01 | 0.226 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.946131e-01 | 0.226 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.946131e-01 | 0.226 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.510756e-01 | 0.346 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.195167e-01 | 0.377 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.918350e-01 | 0.308 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.341185e-01 | 0.272 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.715413e-01 | 0.243 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.169876e-01 | 0.287 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.619747e-01 | 0.250 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.095145e-01 | 0.293 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.567598e-01 | 0.254 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.514137e-01 | 0.259 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.514137e-01 | 0.259 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.350769e-01 | 0.272 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.350769e-01 | 0.272 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.666717e-01 | 0.247 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.787956e-01 | 0.237 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.873570e-01 | 0.231 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.024869e-01 | 0.220 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.024869e-01 | 0.220 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.378906e-01 | 0.195 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.378906e-01 | 0.195 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.378906e-01 | 0.195 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.378906e-01 | 0.195 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.378906e-01 | 0.195 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.870010e-01 | 0.231 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.001912e-01 | 0.222 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.117747e-01 | 0.213 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.117747e-01 | 0.213 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.433259e-01 | 0.192 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.317109e-01 | 0.199 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.317109e-01 | 0.199 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.317109e-01 | 0.199 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.317109e-01 | 0.199 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.541464e-01 | 0.184 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.901905e-01 | 0.161 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.602834e-01 | 0.180 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.576246e-01 | 0.182 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.592282e-01 | 0.181 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.592282e-01 | 0.181 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.765503e-01 | 0.170 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.765503e-01 | 0.170 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.765503e-01 | 0.170 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.765503e-01 | 0.170 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.765503e-01 | 0.170 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.845719e-01 | 0.165 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.845719e-01 | 0.165 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.850701e-01 | 0.164 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.850701e-01 | 0.164 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.122429e-01 | 0.673 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.659338e-01 | 0.575 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.580464e-01 | 0.446 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.420259e-01 | 0.466 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.454027e-01 | 0.351 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.619747e-01 | 0.250 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.619747e-01 | 0.250 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.517478e-01 | 0.345 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.517478e-01 | 0.345 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.413144e-01 | 0.850 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.473384e-01 | 0.189 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.381509e-01 | 0.860 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.659338e-01 | 0.575 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.804794e-01 | 0.318 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.494225e-02 | 1.187 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.218301e-02 | 1.035 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.833070e-01 | 0.416 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.516307e-01 | 0.819 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.453785e-01 | 0.610 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.114272e-01 | 0.675 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.174670e-01 | 0.379 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.343194e-01 | 0.362 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.924960e-01 | 0.406 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.848514e-01 | 0.733 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.905299e-01 | 0.408 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.932605e-01 | 0.405 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.667977e-01 | 0.778 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.723871e-01 | 0.429 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.740709e-01 | 0.562 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.379108e-01 | 0.471 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.209694e-01 | 0.494 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.001912e-01 | 0.222 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.223814e-01 | 0.374 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.833070e-01 | 0.416 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.135083e-01 | 0.671 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.039440e-01 | 0.517 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.012412e-01 | 0.397 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.007272e-01 | 0.300 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.715413e-01 | 0.243 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.991280e-01 | 0.701 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.259548e-01 | 0.646 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 7.595764e-02 | 1.119 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.922424e-01 | 0.406 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.938259e-01 | 0.713 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.310892e-01 | 0.365 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.992643e-01 | 0.524 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.039440e-01 | 0.517 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.708427e-02 | 1.013 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.628981e-01 | 0.580 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.879835e-01 | 0.541 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.122673e-01 | 0.950 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.735259e-01 | 0.761 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.766985e-01 | 0.322 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.865012e-02 | 1.104 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.828304e-01 | 0.738 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.834673e-02 | 1.007 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.922424e-01 | 0.406 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.126854e-01 | 0.505 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.310892e-01 | 0.365 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.102849e-01 | 0.677 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.519328e-01 | 0.818 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.722641e-01 | 0.764 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.685705e-01 | 0.329 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.336466e-01 | 0.631 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.448554e-01 | 0.352 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.356652e-01 | 0.271 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.541464e-01 | 0.184 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.555411e-02 | 1.183 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.871959e-01 | 0.312 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.127810e-01 | 0.290 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.975035e-01 | 0.224 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.407715e-01 | 0.618 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.687282e-01 | 0.571 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.850701e-01 | 0.164 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.000036e-01 | 0.523 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.665035e-01 | 0.176 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.665035e-01 | 0.176 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.535400e-01 | 0.257 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.878325e-01 | 0.726 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.428166e-01 | 0.845 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.086807e-01 | 0.389 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.295095e-01 | 0.888 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.136242e-01 | 0.945 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.113554e-01 | 0.507 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.522385e-01 | 0.453 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.628981e-01 | 0.580 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.529438e-01 | 0.597 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.922424e-01 | 0.406 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.922424e-01 | 0.406 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.922424e-01 | 0.406 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.461663e-01 | 0.263 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.855085e-01 | 0.544 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.905299e-01 | 0.408 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.388801e-01 | 0.269 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.953864e-01 | 0.305 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.335503e-01 | 0.273 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.765503e-01 | 0.170 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.305912e-01 | 0.200 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.838151e-02 | 1.106 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.000464e-01 | 0.699 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.000464e-01 | 0.699 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.871959e-01 | 0.312 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.381509e-01 | 0.860 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.707935e-01 | 0.567 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.379145e-01 | 0.471 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.172847e-01 | 0.499 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.992643e-01 | 0.524 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.845719e-01 | 0.165 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.046840e-01 | 0.393 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.676648e-01 | 0.572 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.720430e-02 | 1.059 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.248225e-01 | 0.372 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.787956e-01 | 0.237 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.490612e-01 | 0.604 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.502803e-01 | 0.456 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.451324e-01 | 0.190 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.012856e-01 | 0.696 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.411842e-01 | 0.618 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.284929e-01 | 0.641 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.317319e-01 | 0.479 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.461663e-01 | 0.263 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.461663e-01 | 0.263 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.461663e-01 | 0.263 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.045352e-01 | 0.297 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.630219e-01 | 0.334 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.630219e-01 | 0.334 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.953864e-01 | 0.305 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.927508e-01 | 0.406 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.715413e-01 | 0.243 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.125139e-01 | 0.385 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.787956e-01 | 0.237 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.024869e-01 | 0.220 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.592282e-01 | 0.181 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.592282e-01 | 0.181 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.765503e-01 | 0.170 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.850701e-01 | 0.164 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.420259e-01 | 0.466 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.833070e-01 | 0.416 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.897844e-01 | 0.229 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.530025e-01 | 0.452 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 1.571743e-01 | 0.804 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.245901e-01 | 0.204 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.275800e-01 | 0.369 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.095145e-01 | 0.293 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.405764e-01 | 0.356 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.790350e-01 | 0.168 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.409543e-01 | 0.193 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.016084e-01 | 0.221 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.474367e-02 | 1.189 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.645427e-02 | 1.177 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.113634e-01 | 0.675 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.113554e-01 | 0.507 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.120672e-01 | 0.674 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.628981e-01 | 0.580 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.919335e-01 | 0.308 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.461663e-01 | 0.263 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.517478e-01 | 0.345 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.905299e-01 | 0.408 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.490260e-01 | 0.348 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.946131e-01 | 0.226 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.946131e-01 | 0.226 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.645833e-01 | 0.248 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.378906e-01 | 0.195 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.378906e-01 | 0.195 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.576246e-01 | 0.182 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.761779e-01 | 0.322 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.177327e-01 | 0.929 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.001912e-01 | 0.222 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.497840e-02 | 1.187 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.845248e-01 | 0.165 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.110883e-01 | 0.954 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.291821e-01 | 0.367 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.522385e-01 | 0.453 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.281532e-01 | 0.892 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.567616e-01 | 0.340 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.095145e-01 | 0.293 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.820825e-01 | 0.235 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.832163e-01 | 0.548 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.775028e-01 | 0.423 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.204987e-01 | 0.376 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.848060e-01 | 0.733 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.811639e-01 | 0.167 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.013666e-01 | 0.994 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.080790e-01 | 0.682 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.223814e-01 | 0.374 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.409543e-01 | 0.193 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.592282e-01 | 0.181 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.863936e-01 | 0.232 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.863936e-01 | 0.232 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.294345e-01 | 0.201 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.838151e-02 | 1.106 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.471853e-01 | 0.262 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.369418e-02 | 1.077 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.535400e-01 | 0.257 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.952041e-02 | 1.158 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.006580e-01 | 0.397 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.873570e-01 | 0.231 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.052282e-01 | 0.978 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.197983e-01 | 0.922 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.433717e-01 | 0.614 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.627146e-01 | 0.440 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.871959e-01 | 0.312 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.841082e-01 | 0.165 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.450347e-01 | 0.839 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.000807e-01 | 0.301 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.172847e-01 | 0.499 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.503947e-01 | 0.823 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.162874e-01 | 0.665 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.369496e-01 | 0.196 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.181443e-01 | 0.286 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.291390e-01 | 0.483 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.405777e-01 | 0.267 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.088197e-02 | 1.092 | 1 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.334168e-02 | 1.135 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.541464e-01 | 0.184 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.988764e-01 | 0.223 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.558628e-02 | 1.020 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.277974e-01 | 0.484 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.053050e-01 | 0.978 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 3.632642e-01 | 0.440 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.484232e-01 | 0.828 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.217612e-01 | 0.914 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.312238e-01 | 0.365 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.312238e-01 | 0.365 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.312238e-01 | 0.365 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.522385e-01 | 0.453 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.522385e-01 | 0.453 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.628981e-01 | 0.580 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.922424e-01 | 0.406 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 4.919335e-01 | 0.308 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 4.919335e-01 | 0.308 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.162874e-01 | 0.665 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.310892e-01 | 0.365 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.172847e-01 | 0.499 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.924960e-01 | 0.406 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.924960e-01 | 0.406 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.832163e-01 | 0.548 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.223814e-01 | 0.374 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.461663e-01 | 0.263 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.461663e-01 | 0.263 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.461663e-01 | 0.263 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.306373e-01 | 0.481 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.903969e-01 | 0.537 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.045352e-01 | 0.297 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.045352e-01 | 0.297 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.490260e-01 | 0.348 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.388801e-01 | 0.269 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.946131e-01 | 0.226 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.946131e-01 | 0.226 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.946131e-01 | 0.226 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.946131e-01 | 0.226 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.715413e-01 | 0.243 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.715413e-01 | 0.243 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.715413e-01 | 0.243 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.024869e-01 | 0.220 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.378906e-01 | 0.195 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.353327e-01 | 0.197 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.304409e-01 | 0.200 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.602495e-01 | 0.180 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.592282e-01 | 0.181 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.765503e-01 | 0.170 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.846915e-01 | 0.415 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.220613e-01 | 0.492 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.077943e-01 | 0.967 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.241127e-01 | 0.489 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.585267e-01 | 0.253 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.580464e-01 | 0.446 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.745936e-01 | 0.171 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.686946e-01 | 0.571 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.922763e-01 | 0.716 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.754384e-01 | 0.425 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.530835e-01 | 0.597 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.971670e-02 | 1.157 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.526772e-01 | 0.344 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.884164e-01 | 0.725 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.936392e-01 | 0.405 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.823049e-01 | 0.317 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.384577e-01 | 0.358 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.317109e-01 | 0.199 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.007272e-01 | 0.300 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.172189e-01 | 0.663 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.776476e-01 | 0.750 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.838151e-02 | 1.106 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.918350e-01 | 0.308 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.765503e-01 | 0.170 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.268647e-01 | 0.486 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.169876e-01 | 0.287 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.214359e-01 | 0.655 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.922424e-01 | 0.406 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.310892e-01 | 0.365 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.446546e-01 | 0.611 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.871959e-01 | 0.312 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.330642e-01 | 0.273 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.790350e-01 | 0.168 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.705737e-01 | 0.568 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.967816e-01 | 0.157 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.851122e-01 | 0.545 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.425170e-01 | 0.846 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.284929e-01 | 0.641 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.696315e-01 | 0.770 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.561900e-01 | 0.806 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.992643e-01 | 0.524 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.481822e-01 | 0.829 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.461663e-01 | 0.263 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.045352e-01 | 0.297 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.086807e-01 | 0.389 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.630219e-01 | 0.334 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.630219e-01 | 0.334 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.388801e-01 | 0.269 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.388801e-01 | 0.269 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.388801e-01 | 0.269 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.388801e-01 | 0.269 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.946131e-01 | 0.226 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.024869e-01 | 0.220 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.765503e-01 | 0.170 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.343194e-01 | 0.362 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.090422e-01 | 0.388 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.090422e-01 | 0.388 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.928197e-01 | 0.159 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.172847e-01 | 0.499 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.126854e-01 | 0.505 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.939834e-01 | 0.405 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.666717e-01 | 0.247 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.094782e-01 | 0.961 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.310892e-01 | 0.365 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.329683e-01 | 0.273 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.117747e-01 | 0.213 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.216877e-01 | 0.206 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.592282e-01 | 0.181 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.409543e-01 | 0.193 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.084786e-01 | 0.294 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.901856e-01 | 0.310 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.143505e-01 | 0.289 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.001912e-01 | 0.222 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.120672e-01 | 0.674 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.433717e-01 | 0.614 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.135777e-01 | 0.383 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.352024e-01 | 0.197 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.733812e-01 | 0.761 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.679032e-01 | 0.246 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.871897e-01 | 0.542 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.284929e-01 | 0.641 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.632642e-01 | 0.440 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.312238e-01 | 0.365 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.312238e-01 | 0.365 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.628981e-01 | 0.580 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.922424e-01 | 0.406 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.919335e-01 | 0.308 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.126854e-01 | 0.505 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.611673e-01 | 0.583 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.310892e-01 | 0.365 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.946131e-01 | 0.226 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.619747e-01 | 0.250 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.619747e-01 | 0.250 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.378906e-01 | 0.195 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.304409e-01 | 0.200 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.304409e-01 | 0.200 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.576246e-01 | 0.182 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.765503e-01 | 0.170 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.765503e-01 | 0.170 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.788946e-01 | 0.168 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.850701e-01 | 0.164 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.194921e-01 | 0.284 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.078347e-01 | 0.967 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.235037e-01 | 0.908 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.952876e-01 | 0.709 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.743384e-02 | 1.058 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.332695e-01 | 0.273 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 6.024869e-01 | 0.220 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.787955e-01 | 0.168 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.800684e-01 | 0.553 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.186972e-01 | 0.497 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.378906e-01 | 0.195 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.317109e-01 | 0.199 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.743384e-02 | 1.058 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.044288e-01 | 0.219 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.800684e-01 | 0.553 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.317109e-01 | 0.199 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.925540e-01 | 0.227 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.414812e-01 | 0.193 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.312238e-01 | 0.365 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.312238e-01 | 0.365 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.919335e-01 | 0.308 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.919335e-01 | 0.308 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.343194e-01 | 0.362 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.567616e-01 | 0.340 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.946131e-01 | 0.226 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.946131e-01 | 0.226 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 5.715413e-01 | 0.243 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.567598e-01 | 0.254 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.873570e-01 | 0.231 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.378906e-01 | 0.195 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.378906e-01 | 0.195 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.044288e-01 | 0.219 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.409543e-01 | 0.193 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.765503e-01 | 0.170 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.740709e-01 | 0.562 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.554494e-01 | 0.808 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.790350e-01 | 0.168 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.834673e-02 | 1.007 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.283296e-01 | 0.892 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.622274e-01 | 0.441 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.145887e-01 | 0.502 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.946131e-01 | 0.226 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.946131e-01 | 0.226 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.873570e-01 | 0.231 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.024869e-01 | 0.220 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.378906e-01 | 0.195 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.378906e-01 | 0.195 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.117747e-01 | 0.213 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.317109e-01 | 0.199 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.765503e-01 | 0.170 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.628981e-01 | 0.580 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.924960e-01 | 0.406 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.924960e-01 | 0.406 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.632104e-01 | 0.440 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.174670e-01 | 0.379 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.461663e-01 | 0.263 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.084786e-01 | 0.294 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.873570e-01 | 0.231 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.378906e-01 | 0.195 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.352024e-01 | 0.197 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.850701e-01 | 0.164 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.388801e-01 | 0.269 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.619747e-01 | 0.250 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.715413e-01 | 0.243 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.288612e-01 | 0.201 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.310892e-01 | 0.365 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.787956e-01 | 0.237 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.736060e-01 | 0.172 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.787956e-01 | 0.237 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.706419e-01 | 0.244 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.117747e-01 | 0.213 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.461663e-01 | 0.263 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.972356e-01 | 0.157 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.972356e-01 | 0.157 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.972356e-01 | 0.157 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.994353e-01 | 0.155 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.994353e-01 | 0.155 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.994353e-01 | 0.155 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.016793e-01 | 0.154 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.057830e-01 | 0.151 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.092807e-01 | 0.149 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.092807e-01 | 0.149 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.092807e-01 | 0.149 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.092807e-01 | 0.149 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.092807e-01 | 0.149 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.110846e-01 | 0.148 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.110846e-01 | 0.148 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.110846e-01 | 0.148 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.110846e-01 | 0.148 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.110846e-01 | 0.148 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.110846e-01 | 0.148 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.110846e-01 | 0.148 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.110846e-01 | 0.148 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.110846e-01 | 0.148 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.110846e-01 | 0.148 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.110846e-01 | 0.148 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.110846e-01 | 0.148 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.110846e-01 | 0.148 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.110846e-01 | 0.148 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.110846e-01 | 0.148 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.127397e-01 | 0.147 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.127397e-01 | 0.147 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.128978e-01 | 0.147 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.128978e-01 | 0.147 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.139424e-01 | 0.146 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.139424e-01 | 0.146 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.139424e-01 | 0.146 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.187418e-01 | 0.143 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.188337e-01 | 0.143 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.188337e-01 | 0.143 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.188337e-01 | 0.143 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.254499e-01 | 0.139 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.270831e-01 | 0.138 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.272126e-01 | 0.138 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.276743e-01 | 0.138 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.276743e-01 | 0.138 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.319135e-01 | 0.136 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.319135e-01 | 0.136 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.319135e-01 | 0.136 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.319135e-01 | 0.136 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.319135e-01 | 0.136 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.319135e-01 | 0.136 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.319135e-01 | 0.136 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.360792e-01 | 0.133 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.369768e-01 | 0.133 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.372445e-01 | 0.132 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.372445e-01 | 0.132 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.372445e-01 | 0.132 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.404452e-01 | 0.131 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.409583e-01 | 0.130 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.419336e-01 | 0.130 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.419336e-01 | 0.130 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.419336e-01 | 0.130 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.419336e-01 | 0.130 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.419336e-01 | 0.130 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.419336e-01 | 0.130 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.419336e-01 | 0.130 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.419336e-01 | 0.130 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.419336e-01 | 0.130 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.419336e-01 | 0.130 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.419336e-01 | 0.130 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.419336e-01 | 0.130 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.419336e-01 | 0.130 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.420403e-01 | 0.130 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.449022e-01 | 0.128 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.449022e-01 | 0.128 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.460973e-01 | 0.127 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.460973e-01 | 0.127 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.460973e-01 | 0.127 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.471856e-01 | 0.127 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.478431e-01 | 0.126 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.524192e-01 | 0.124 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.526270e-01 | 0.123 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.526292e-01 | 0.123 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.530296e-01 | 0.123 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.530296e-01 | 0.123 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.530296e-01 | 0.123 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.530296e-01 | 0.123 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.530296e-01 | 0.123 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.546865e-01 | 0.122 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.546865e-01 | 0.122 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.546865e-01 | 0.122 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.546865e-01 | 0.122 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.546865e-01 | 0.122 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.546865e-01 | 0.122 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.546865e-01 | 0.122 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.550138e-01 | 0.122 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.557648e-01 | 0.122 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.558406e-01 | 0.122 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.611055e-01 | 0.119 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.611055e-01 | 0.119 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.619876e-01 | 0.118 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.639057e-01 | 0.117 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.687247e-01 | 0.114 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.694902e-01 | 0.114 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.694902e-01 | 0.114 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.694902e-01 | 0.114 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.694902e-01 | 0.114 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.694902e-01 | 0.114 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.694902e-01 | 0.114 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.694902e-01 | 0.114 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.711125e-01 | 0.113 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.711831e-01 | 0.113 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.711831e-01 | 0.113 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.711831e-01 | 0.113 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.711831e-01 | 0.113 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.726946e-01 | 0.112 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.726946e-01 | 0.112 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.726946e-01 | 0.112 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.726946e-01 | 0.112 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.726946e-01 | 0.112 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.726946e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.741069e-01 | 0.111 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.741069e-01 | 0.111 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.751688e-01 | 0.111 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.753655e-01 | 0.110 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.754148e-01 | 0.110 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.762139e-01 | 0.110 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.817349e-01 | 0.107 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.817657e-01 | 0.107 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.841979e-01 | 0.106 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.857261e-01 | 0.105 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.867604e-01 | 0.104 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.889273e-01 | 0.103 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.890388e-01 | 0.103 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.890388e-01 | 0.103 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.901157e-01 | 0.102 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.909777e-01 | 0.102 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.909777e-01 | 0.102 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.909777e-01 | 0.102 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.909777e-01 | 0.102 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.928164e-01 | 0.101 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.933822e-01 | 0.101 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 7.941058e-01 | 0.100 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.941058e-01 | 0.100 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.941058e-01 | 0.100 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.941058e-01 | 0.100 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.941058e-01 | 0.100 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.941058e-01 | 0.100 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.941058e-01 | 0.100 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.941058e-01 | 0.100 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.941058e-01 | 0.100 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.941058e-01 | 0.100 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.941058e-01 | 0.100 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.941058e-01 | 0.100 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.942682e-01 | 0.100 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.963378e-01 | 0.099 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.963378e-01 | 0.099 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.963378e-01 | 0.099 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.963378e-01 | 0.099 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.982143e-01 | 0.098 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.990814e-01 | 0.097 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.998913e-01 | 0.097 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.014476e-01 | 0.096 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.019930e-01 | 0.096 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.019930e-01 | 0.096 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.019930e-01 | 0.096 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.022055e-01 | 0.096 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.055099e-01 | 0.094 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.067922e-01 | 0.093 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.079496e-01 | 0.093 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.079496e-01 | 0.093 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.079496e-01 | 0.093 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.079496e-01 | 0.093 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.092996e-01 | 0.092 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.092996e-01 | 0.092 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.098322e-01 | 0.092 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.104094e-01 | 0.091 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.142945e-01 | 0.089 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.152757e-01 | 0.089 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.152757e-01 | 0.089 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.160940e-01 | 0.088 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.160940e-01 | 0.088 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.160940e-01 | 0.088 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.160940e-01 | 0.088 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.160940e-01 | 0.088 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.160940e-01 | 0.088 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.160940e-01 | 0.088 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.160940e-01 | 0.088 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.165894e-01 | 0.088 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.184479e-01 | 0.087 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.185076e-01 | 0.087 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.204895e-01 | 0.086 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.236819e-01 | 0.084 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.236819e-01 | 0.084 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.236819e-01 | 0.084 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.236819e-01 | 0.084 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.236819e-01 | 0.084 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.236819e-01 | 0.084 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.259130e-01 | 0.083 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.282773e-01 | 0.082 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.282773e-01 | 0.082 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.282773e-01 | 0.082 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.282773e-01 | 0.082 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.307926e-01 | 0.081 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.313166e-01 | 0.080 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.313898e-01 | 0.080 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.338047e-01 | 0.079 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.340809e-01 | 0.079 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.357352e-01 | 0.078 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.357352e-01 | 0.078 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.357352e-01 | 0.078 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.357352e-01 | 0.078 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.357352e-01 | 0.078 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.357352e-01 | 0.078 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.357352e-01 | 0.078 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.357352e-01 | 0.078 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.357352e-01 | 0.078 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.357352e-01 | 0.078 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 8.357352e-01 | 0.078 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.357352e-01 | 0.078 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.357352e-01 | 0.078 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.357352e-01 | 0.078 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.357352e-01 | 0.078 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.357352e-01 | 0.078 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.370146e-01 | 0.077 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.370146e-01 | 0.077 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.372235e-01 | 0.077 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.382457e-01 | 0.077 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.393713e-01 | 0.076 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.404861e-01 | 0.075 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.404861e-01 | 0.075 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.404861e-01 | 0.075 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.404861e-01 | 0.075 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.404861e-01 | 0.075 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.425958e-01 | 0.074 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.440757e-01 | 0.074 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.449230e-01 | 0.073 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.468049e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.468049e-01 | 0.072 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.474732e-01 | 0.072 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.474732e-01 | 0.072 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.480585e-01 | 0.072 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.507572e-01 | 0.070 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.514011e-01 | 0.070 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.517110e-01 | 0.070 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.517110e-01 | 0.070 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.517110e-01 | 0.070 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.519364e-01 | 0.070 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.519364e-01 | 0.070 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.519364e-01 | 0.070 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.528860e-01 | 0.069 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.532797e-01 | 0.069 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.532797e-01 | 0.069 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.532797e-01 | 0.069 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.532797e-01 | 0.069 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.532797e-01 | 0.069 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.532797e-01 | 0.069 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.532797e-01 | 0.069 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.566145e-01 | 0.067 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.585733e-01 | 0.066 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.637233e-01 | 0.064 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.637233e-01 | 0.064 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.637233e-01 | 0.064 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.641463e-01 | 0.063 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.644749e-01 | 0.063 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.644749e-01 | 0.063 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.644749e-01 | 0.063 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.666930e-01 | 0.062 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.666930e-01 | 0.062 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.679317e-01 | 0.062 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.689513e-01 | 0.061 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.689513e-01 | 0.061 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.689513e-01 | 0.061 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.689513e-01 | 0.061 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.689513e-01 | 0.061 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.689513e-01 | 0.061 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.689513e-01 | 0.061 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 8.689513e-01 | 0.061 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.689513e-01 | 0.061 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.689513e-01 | 0.061 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.689513e-01 | 0.061 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.689513e-01 | 0.061 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.689513e-01 | 0.061 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.689513e-01 | 0.061 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.715418e-01 | 0.060 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.723048e-01 | 0.059 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.727793e-01 | 0.059 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.740731e-01 | 0.058 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.756181e-01 | 0.058 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.756181e-01 | 0.058 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.756181e-01 | 0.058 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.756181e-01 | 0.058 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.756181e-01 | 0.058 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.789239e-01 | 0.056 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.829498e-01 | 0.054 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.829498e-01 | 0.054 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.829498e-01 | 0.054 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.829498e-01 | 0.054 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.829498e-01 | 0.054 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.829498e-01 | 0.054 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.829498e-01 | 0.054 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.829498e-01 | 0.054 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.829498e-01 | 0.054 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.829498e-01 | 0.054 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.829498e-01 | 0.054 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 8.829498e-01 | 0.054 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.829498e-01 | 0.054 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.829498e-01 | 0.054 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.837941e-01 | 0.054 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.861901e-01 | 0.052 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.861901e-01 | 0.052 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.861901e-01 | 0.052 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.875230e-01 | 0.052 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.908419e-01 | 0.050 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.916049e-01 | 0.050 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.921930e-01 | 0.050 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.954537e-01 | 0.048 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.954537e-01 | 0.048 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.954537e-01 | 0.048 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.954537e-01 | 0.048 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.954537e-01 | 0.048 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.954537e-01 | 0.048 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.954537e-01 | 0.048 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.954537e-01 | 0.048 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.954537e-01 | 0.048 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.954537e-01 | 0.048 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.959236e-01 | 0.048 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.959236e-01 | 0.048 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.963622e-01 | 0.048 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.987149e-01 | 0.046 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.989516e-01 | 0.046 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.989516e-01 | 0.046 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.990144e-01 | 0.046 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.990144e-01 | 0.046 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.990144e-01 | 0.046 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.993953e-01 | 0.046 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.011376e-01 | 0.045 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.015202e-01 | 0.045 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.021686e-01 | 0.045 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.048772e-01 | 0.043 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.048772e-01 | 0.043 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.048772e-01 | 0.043 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.048772e-01 | 0.043 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.048772e-01 | 0.043 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.058555e-01 | 0.043 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.058555e-01 | 0.043 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.065239e-01 | 0.043 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.066225e-01 | 0.043 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.066225e-01 | 0.043 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.066225e-01 | 0.043 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.066225e-01 | 0.043 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.066225e-01 | 0.043 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.066225e-01 | 0.043 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 9.066225e-01 | 0.043 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.066312e-01 | 0.043 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.066312e-01 | 0.043 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.094647e-01 | 0.041 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.099196e-01 | 0.041 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.108442e-01 | 0.041 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.131063e-01 | 0.039 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.131063e-01 | 0.039 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.137238e-01 | 0.039 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.137238e-01 | 0.039 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.145728e-01 | 0.039 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.149176e-01 | 0.039 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.165987e-01 | 0.038 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.165987e-01 | 0.038 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 9.165987e-01 | 0.038 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.165987e-01 | 0.038 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.165987e-01 | 0.038 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.165987e-01 | 0.038 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.165987e-01 | 0.038 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.184196e-01 | 0.037 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.190199e-01 | 0.037 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.203225e-01 | 0.036 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.203225e-01 | 0.036 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.208599e-01 | 0.036 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.213996e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.234631e-01 | 0.035 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.241205e-01 | 0.034 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.241205e-01 | 0.034 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.252482e-01 | 0.034 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.255097e-01 | 0.034 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.255097e-01 | 0.034 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.255097e-01 | 0.034 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.255097e-01 | 0.034 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.255355e-01 | 0.034 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.275984e-01 | 0.033 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.275984e-01 | 0.033 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.275984e-01 | 0.033 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.287408e-01 | 0.032 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.294606e-01 | 0.032 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.307304e-01 | 0.031 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.307304e-01 | 0.031 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.311817e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.311817e-01 | 0.031 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.321546e-01 | 0.031 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.334690e-01 | 0.030 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.334690e-01 | 0.030 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.334690e-01 | 0.030 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.334690e-01 | 0.030 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.334690e-01 | 0.030 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.334690e-01 | 0.030 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.334690e-01 | 0.030 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.334690e-01 | 0.030 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.334690e-01 | 0.030 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.334690e-01 | 0.030 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.341595e-01 | 0.030 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.350157e-01 | 0.029 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.350181e-01 | 0.029 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.351940e-01 | 0.029 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.354933e-01 | 0.029 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.374432e-01 | 0.028 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.383858e-01 | 0.028 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.388957e-01 | 0.027 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.391336e-01 | 0.027 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.397850e-01 | 0.027 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.397850e-01 | 0.027 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.397850e-01 | 0.027 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.405782e-01 | 0.027 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.405782e-01 | 0.027 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.405782e-01 | 0.027 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.405782e-01 | 0.027 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.405782e-01 | 0.027 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.405782e-01 | 0.027 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.405782e-01 | 0.027 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.405782e-01 | 0.027 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.413565e-01 | 0.026 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.413565e-01 | 0.026 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.423483e-01 | 0.026 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.424931e-01 | 0.026 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.424931e-01 | 0.026 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.428925e-01 | 0.026 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.435029e-01 | 0.025 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.451216e-01 | 0.025 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.451216e-01 | 0.025 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.451216e-01 | 0.025 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.451216e-01 | 0.025 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.451216e-01 | 0.025 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.451216e-01 | 0.025 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.465296e-01 | 0.024 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.468945e-01 | 0.024 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.469282e-01 | 0.024 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.469282e-01 | 0.024 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.469282e-01 | 0.024 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.469282e-01 | 0.024 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.469282e-01 | 0.024 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.469282e-01 | 0.024 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.469282e-01 | 0.024 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.469282e-01 | 0.024 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.469282e-01 | 0.024 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.469282e-01 | 0.024 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.471781e-01 | 0.024 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.475838e-01 | 0.023 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.475838e-01 | 0.023 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.475838e-01 | 0.023 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.490174e-01 | 0.023 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.490174e-01 | 0.023 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.499745e-01 | 0.022 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.499745e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.500057e-01 | 0.022 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.500057e-01 | 0.022 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.526000e-01 | 0.021 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.526000e-01 | 0.021 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.526000e-01 | 0.021 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.526000e-01 | 0.021 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.526000e-01 | 0.021 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.544730e-01 | 0.020 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.544730e-01 | 0.020 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.544730e-01 | 0.020 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.549459e-01 | 0.020 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.550025e-01 | 0.020 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.564933e-01 | 0.019 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.565110e-01 | 0.019 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.565612e-01 | 0.019 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.565612e-01 | 0.019 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.565612e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.576659e-01 | 0.019 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.576659e-01 | 0.019 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.576659e-01 | 0.019 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.576659e-01 | 0.019 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.576659e-01 | 0.019 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.585569e-01 | 0.018 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.591904e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.595483e-01 | 0.018 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.614219e-01 | 0.017 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.618260e-01 | 0.017 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.619403e-01 | 0.017 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.621906e-01 | 0.017 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.621906e-01 | 0.017 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.621906e-01 | 0.017 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.621906e-01 | 0.017 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.621906e-01 | 0.017 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.621906e-01 | 0.017 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.621906e-01 | 0.017 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.621906e-01 | 0.017 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.621906e-01 | 0.017 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.621906e-01 | 0.017 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.621906e-01 | 0.017 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.622881e-01 | 0.017 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.650193e-01 | 0.015 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.650193e-01 | 0.015 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.650193e-01 | 0.015 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.656956e-01 | 0.015 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.662320e-01 | 0.015 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.662320e-01 | 0.015 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.662320e-01 | 0.015 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.662320e-01 | 0.015 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.662320e-01 | 0.015 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.662320e-01 | 0.015 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.662320e-01 | 0.015 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.662320e-01 | 0.015 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.662320e-01 | 0.015 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.668898e-01 | 0.015 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.670163e-01 | 0.015 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.671155e-01 | 0.015 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.678623e-01 | 0.014 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.684787e-01 | 0.014 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.688057e-01 | 0.014 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.688057e-01 | 0.014 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.688057e-01 | 0.014 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.688057e-01 | 0.014 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.688462e-01 | 0.014 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.693760e-01 | 0.014 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.698416e-01 | 0.013 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.698416e-01 | 0.013 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.698416e-01 | 0.013 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.698416e-01 | 0.013 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.698416e-01 | 0.013 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.698416e-01 | 0.013 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.700639e-01 | 0.013 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.716431e-01 | 0.012 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.718471e-01 | 0.012 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.730655e-01 | 0.012 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.738470e-01 | 0.012 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.742306e-01 | 0.011 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.742306e-01 | 0.011 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.742306e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.742306e-01 | 0.011 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.745765e-01 | 0.011 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.758272e-01 | 0.011 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.758272e-01 | 0.011 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.759450e-01 | 0.011 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.759450e-01 | 0.011 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.759450e-01 | 0.011 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.759450e-01 | 0.011 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.759450e-01 | 0.011 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.759450e-01 | 0.011 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.759450e-01 | 0.011 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.759450e-01 | 0.011 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.771927e-01 | 0.010 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.773593e-01 | 0.010 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.774563e-01 | 0.010 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.785168e-01 | 0.009 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.785168e-01 | 0.009 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.785168e-01 | 0.009 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.785168e-01 | 0.009 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.785168e-01 | 0.009 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.785168e-01 | 0.009 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.787018e-01 | 0.009 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.787382e-01 | 0.009 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.787382e-01 | 0.009 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.787382e-01 | 0.009 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.790859e-01 | 0.009 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.794496e-01 | 0.009 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.802207e-01 | 0.009 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.805961e-01 | 0.009 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.806954e-01 | 0.008 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.808138e-01 | 0.008 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.808138e-01 | 0.008 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.808286e-01 | 0.008 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.808286e-01 | 0.008 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.808613e-01 | 0.008 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.814466e-01 | 0.008 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.814466e-01 | 0.008 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.824321e-01 | 0.008 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.824321e-01 | 0.008 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.824321e-01 | 0.008 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.824321e-01 | 0.008 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.824321e-01 | 0.008 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.824321e-01 | 0.008 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.824783e-01 | 0.008 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.824783e-01 | 0.008 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.824783e-01 | 0.008 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.828653e-01 | 0.008 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.828653e-01 | 0.008 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.835160e-01 | 0.007 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.840889e-01 | 0.007 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.840990e-01 | 0.007 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.840990e-01 | 0.007 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.846975e-01 | 0.007 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.846975e-01 | 0.007 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.846975e-01 | 0.007 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.846975e-01 | 0.007 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.850888e-01 | 0.007 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.852625e-01 | 0.006 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.852625e-01 | 0.006 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.855744e-01 | 0.006 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.863339e-01 | 0.006 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.863339e-01 | 0.006 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.863339e-01 | 0.006 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.865021e-01 | 0.006 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.865530e-01 | 0.006 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.867447e-01 | 0.006 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.877297e-01 | 0.005 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.877954e-01 | 0.005 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.877954e-01 | 0.005 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.877954e-01 | 0.005 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.877954e-01 | 0.005 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.881360e-01 | 0.005 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.881360e-01 | 0.005 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.881360e-01 | 0.005 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.881360e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.883426e-01 | 0.005 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.892001e-01 | 0.005 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.894462e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.894957e-01 | 0.005 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.900468e-01 | 0.004 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.900579e-01 | 0.004 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.900638e-01 | 0.004 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.901033e-01 | 0.004 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.901106e-01 | 0.004 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.902521e-01 | 0.004 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.902665e-01 | 0.004 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.902665e-01 | 0.004 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.902665e-01 | 0.004 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.902665e-01 | 0.004 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.903165e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.905522e-01 | 0.004 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.906365e-01 | 0.004 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.911671e-01 | 0.004 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.913076e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.913076e-01 | 0.004 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.913636e-01 | 0.004 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.917010e-01 | 0.004 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.922374e-01 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.922374e-01 | 0.003 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.922374e-01 | 0.003 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.923138e-01 | 0.003 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.927521e-01 | 0.003 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.927893e-01 | 0.003 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.929152e-01 | 0.003 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.929152e-01 | 0.003 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.930678e-01 | 0.003 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.930678e-01 | 0.003 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.930678e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.930678e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.930678e-01 | 0.003 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.930678e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.930678e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.934139e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.934139e-01 | 0.003 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.938095e-01 | 0.003 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.938095e-01 | 0.003 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.938095e-01 | 0.003 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.938095e-01 | 0.003 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.940576e-01 | 0.003 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.944066e-01 | 0.002 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.944718e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.944718e-01 | 0.002 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.944718e-01 | 0.002 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.949891e-01 | 0.002 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.950633e-01 | 0.002 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.950633e-01 | 0.002 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.950633e-01 | 0.002 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.950633e-01 | 0.002 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.950633e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.950633e-01 | 0.002 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.950633e-01 | 0.002 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.950633e-01 | 0.002 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.952767e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.954277e-01 | 0.002 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.954277e-01 | 0.002 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.955915e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.955915e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.955950e-01 | 0.002 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.955995e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.960148e-01 | 0.002 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.960632e-01 | 0.002 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.960632e-01 | 0.002 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.960632e-01 | 0.002 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.961256e-01 | 0.002 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.963065e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.963952e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.963952e-01 | 0.002 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.964845e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.964845e-01 | 0.002 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.964845e-01 | 0.002 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.964845e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.965313e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.967399e-01 | 0.001 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.967399e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.968399e-01 | 0.001 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.968608e-01 | 0.001 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.968608e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.968608e-01 | 0.001 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.969999e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.969999e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.970521e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.970899e-01 | 0.001 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.971967e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.971967e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.972500e-01 | 0.001 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.973236e-01 | 0.001 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.973349e-01 | 0.001 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.973674e-01 | 0.001 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.974968e-01 | 0.001 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.974968e-01 | 0.001 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.974968e-01 | 0.001 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.977647e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.978116e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.978207e-01 | 0.001 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.979335e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.980040e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.980324e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.981022e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.981855e-01 | 0.001 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.982177e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.982177e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.982222e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.982347e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.982350e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.982350e-01 | 0.001 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.983768e-01 | 0.001 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.984134e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.985743e-01 | 0.001 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.986378e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.986899e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.987310e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.987310e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.987310e-01 | 0.001 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.987601e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.988422e-01 | 0.001 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.988622e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.989747e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.989882e-01 | 0.000 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.990966e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.991763e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.991933e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.992051e-01 | 0.000 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.992296e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.992797e-01 | 0.000 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.993068e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.993569e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.993569e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.993603e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.993603e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.993637e-01 | 0.000 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.993939e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.994873e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.994873e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.995231e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.995422e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.995422e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.995422e-01 | 0.000 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.995913e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.995913e-01 | 0.000 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.995989e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.996067e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.996430e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.996759e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.997091e-01 | 0.000 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.997168e-01 | 0.000 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.997402e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.997476e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997771e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997929e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.998091e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.998151e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.998152e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998526e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998779e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998893e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.998904e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.998951e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999064e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999164e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999273e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999405e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999405e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999545e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999577e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999606e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999699e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999720e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999720e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999746e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999766e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.999817e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999846e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999846e-01 | 0.000 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.999864e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999909e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999914e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999939e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999945e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999975e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999980e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999985e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999986e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999988e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999990e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999991e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999992e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999995e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999999e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999999e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.997602e-15 | 14.523 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.342349e-12 | 11.630 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.117839e-12 | 11.506 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.026523e-11 | 10.989 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.471934e-11 | 10.832 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.829548e-11 | 10.417 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.457690e-11 | 10.190 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.210466e-11 | 10.142 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.297396e-11 | 10.081 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.828209e-10 | 9.548 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.575410e-10 | 9.589 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.575410e-10 | 9.589 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.717611e-10 | 9.430 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.762849e-10 | 9.424 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.432459e-10 | 9.353 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.709505e-10 | 9.060 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.117484e-09 | 8.952 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.193723e-09 | 8.923 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.737399e-09 | 8.760 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.789436e-09 | 8.554 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.821633e-09 | 8.317 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.732802e-09 | 8.172 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.631947e-09 | 8.178 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.276196e-08 | 7.894 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.766913e-08 | 7.558 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.282033e-08 | 7.484 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.813216e-08 | 7.419 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.400066e-08 | 7.357 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.400066e-08 | 7.357 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.607450e-08 | 7.337 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.665958e-08 | 7.331 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.018602e-08 | 7.299 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.448943e-08 | 7.264 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.540914e-08 | 7.184 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.973054e-08 | 7.157 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.817313e-08 | 7.166 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.044401e-08 | 7.152 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.216628e-08 | 7.035 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.231631e-07 | 6.910 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.202455e-07 | 6.920 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.199555e-07 | 6.921 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.477661e-07 | 6.830 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.617505e-07 | 6.791 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.641995e-07 | 6.785 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.709271e-07 | 6.767 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.125142e-07 | 6.673 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.125142e-07 | 6.673 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.412942e-07 | 6.617 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.500255e-07 | 6.602 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.844895e-07 | 6.546 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.912215e-07 | 6.536 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.728742e-07 | 6.564 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.836555e-07 | 6.547 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.918394e-07 | 6.535 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.360932e-07 | 6.474 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.587186e-07 | 6.445 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.468695e-07 | 6.460 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.834969e-07 | 6.416 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.023292e-07 | 6.395 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.385590e-07 | 6.358 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.684081e-07 | 6.329 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.638288e-07 | 6.334 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.770158e-07 | 6.321 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.617470e-07 | 6.250 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.672982e-07 | 6.176 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.235530e-07 | 6.141 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.265110e-07 | 6.083 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.190920e-07 | 6.037 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.076220e-06 | 5.968 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.215803e-06 | 5.915 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.215803e-06 | 5.915 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.212272e-06 | 5.916 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.299626e-06 | 5.886 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.693757e-06 | 5.771 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.198986e-06 | 5.658 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.198986e-06 | 5.658 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.239287e-06 | 5.650 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.377871e-06 | 5.624 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.735742e-06 | 5.563 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.741746e-06 | 5.562 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.891621e-06 | 5.539 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.118166e-06 | 5.506 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.324154e-06 | 5.478 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.380179e-06 | 5.471 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.086488e-06 | 5.389 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.891858e-06 | 5.410 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.891858e-06 | 5.410 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.456956e-06 | 5.351 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.562314e-06 | 5.341 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.919285e-06 | 5.308 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.952663e-06 | 5.305 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.311482e-06 | 5.275 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.678463e-06 | 5.246 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.787345e-06 | 5.238 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.204819e-06 | 5.207 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.257029e-06 | 5.204 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.306089e-06 | 5.136 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.950796e-06 | 5.048 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.086947e-06 | 5.042 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.015422e-05 | 4.993 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.019379e-05 | 4.992 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.167882e-05 | 4.933 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.307068e-05 | 4.884 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.497632e-05 | 4.825 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.499844e-05 | 4.824 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.634338e-05 | 4.787 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.650085e-05 | 4.782 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.650085e-05 | 4.782 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.012455e-05 | 4.696 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.079244e-05 | 4.682 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.084911e-05 | 4.681 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.207456e-05 | 4.656 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.288658e-05 | 4.640 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.445576e-05 | 4.612 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.476026e-05 | 4.606 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.548314e-05 | 4.594 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.732909e-05 | 4.563 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.732909e-05 | 4.563 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.995891e-05 | 4.523 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.530132e-05 | 4.452 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.566541e-05 | 4.448 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.566541e-05 | 4.448 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.778767e-05 | 4.423 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.808749e-05 | 4.419 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.053926e-05 | 4.392 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.795190e-05 | 4.421 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.239293e-05 | 4.373 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.578485e-05 | 4.339 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.578485e-05 | 4.339 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.578485e-05 | 4.339 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.833329e-05 | 4.316 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.363330e-05 | 4.196 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.370057e-05 | 4.196 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.781989e-05 | 4.169 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.043502e-05 | 4.152 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.117254e-05 | 4.148 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.319345e-05 | 4.136 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.319345e-05 | 4.136 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.613784e-05 | 4.118 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.680721e-05 | 4.115 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.680721e-05 | 4.115 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.680721e-05 | 4.115 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.724489e-05 | 4.112 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.724946e-05 | 4.059 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.666825e-05 | 4.015 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.627509e-05 | 4.016 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.795747e-05 | 4.009 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.637475e-05 | 4.016 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.795747e-05 | 4.009 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.002769e-04 | 3.999 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.117539e-04 | 3.952 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.119938e-04 | 3.951 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.160434e-04 | 3.935 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.290495e-04 | 3.889 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.295254e-04 | 3.888 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.390758e-04 | 3.857 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.685283e-04 | 3.773 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.685283e-04 | 3.773 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.647097e-04 | 3.783 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.715827e-04 | 3.766 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.559061e-04 | 3.807 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.612719e-04 | 3.792 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.787648e-04 | 3.748 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.787648e-04 | 3.748 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.791674e-04 | 3.747 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.791674e-04 | 3.747 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.824606e-04 | 3.739 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.995917e-04 | 3.700 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.037826e-04 | 3.691 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.184121e-04 | 3.661 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.184121e-04 | 3.661 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.184121e-04 | 3.661 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.184121e-04 | 3.661 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.184121e-04 | 3.661 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.261574e-04 | 3.646 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.621430e-04 | 3.581 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.415328e-04 | 3.617 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.357651e-04 | 3.628 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.524466e-04 | 3.598 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.561166e-04 | 3.592 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.666754e-04 | 3.574 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.765013e-04 | 3.558 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.765013e-04 | 3.558 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.767637e-04 | 3.558 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.774808e-04 | 3.557 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.841615e-04 | 3.546 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.410042e-04 | 3.467 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.421298e-04 | 3.466 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.514700e-04 | 3.454 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.514700e-04 | 3.454 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.054047e-04 | 3.392 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.075818e-04 | 3.390 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.174593e-04 | 3.379 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.225233e-04 | 3.374 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.300989e-04 | 3.366 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.640978e-04 | 3.333 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.665713e-04 | 3.331 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.750678e-04 | 3.323 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.750678e-04 | 3.323 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.843752e-04 | 3.315 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.121057e-04 | 3.291 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.492484e-04 | 3.260 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.776668e-04 | 3.238 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.453872e-04 | 3.263 | 0 | 0 |
| Translation | R-HSA-72766 | 5.962692e-04 | 3.225 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.059195e-04 | 3.218 | 1 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.079184e-04 | 3.216 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.500844e-04 | 3.187 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.550161e-04 | 3.184 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.568154e-04 | 3.183 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.699996e-04 | 3.174 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.815922e-04 | 3.166 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.862838e-04 | 3.163 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.427584e-04 | 3.129 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.767189e-04 | 3.110 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.965739e-04 | 3.099 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.965739e-04 | 3.099 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.270783e-04 | 3.082 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.378311e-04 | 3.077 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.714128e-04 | 3.060 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.797392e-04 | 3.056 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.897918e-04 | 3.051 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.453236e-04 | 3.024 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.005331e-03 | 2.998 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.013650e-03 | 2.994 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.085291e-03 | 2.964 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.085291e-03 | 2.964 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.102560e-03 | 2.958 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.115452e-03 | 2.953 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.115452e-03 | 2.953 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.148560e-03 | 2.940 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.257512e-03 | 2.900 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.262911e-03 | 2.899 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.562163e-03 | 2.806 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.562163e-03 | 2.806 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.537431e-03 | 2.813 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.374497e-03 | 2.862 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.522656e-03 | 2.817 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.620230e-03 | 2.790 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.684384e-03 | 2.774 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.711527e-03 | 2.767 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.725263e-03 | 2.763 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.752124e-03 | 2.756 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.762810e-03 | 2.754 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.795042e-03 | 2.746 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.838537e-03 | 2.736 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.915319e-03 | 2.718 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.918213e-03 | 2.717 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.938486e-03 | 2.713 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.975083e-03 | 2.704 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.108359e-03 | 2.676 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.188152e-03 | 2.660 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.296846e-03 | 2.639 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.340837e-03 | 2.631 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.355641e-03 | 2.628 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.491520e-03 | 2.604 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.559672e-03 | 2.592 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.622999e-03 | 2.581 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.643843e-03 | 2.578 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.913706e-03 | 2.536 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.922483e-03 | 2.534 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.928913e-03 | 2.533 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.940980e-03 | 2.532 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.956810e-03 | 2.529 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.963301e-03 | 2.528 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.991997e-03 | 2.524 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.665499e-03 | 2.436 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.281607e-03 | 2.484 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.307880e-03 | 2.480 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.590310e-03 | 2.445 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.554769e-03 | 2.449 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.554769e-03 | 2.449 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.517065e-03 | 2.454 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.057815e-03 | 2.515 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.108793e-03 | 2.507 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.714719e-03 | 2.430 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.877460e-03 | 2.411 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.934945e-03 | 2.405 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.004230e-03 | 2.397 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.007469e-03 | 2.397 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.007469e-03 | 2.397 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.118990e-03 | 2.385 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.220751e-03 | 2.375 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.244633e-03 | 2.372 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.345901e-03 | 2.362 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.405682e-03 | 2.356 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.435546e-03 | 2.353 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.572720e-03 | 2.340 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.923653e-03 | 2.308 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.994491e-03 | 2.302 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.091423e-03 | 2.293 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.091423e-03 | 2.293 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.623415e-03 | 2.250 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.652060e-03 | 2.248 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.738196e-03 | 2.241 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.764388e-03 | 2.239 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.873830e-03 | 2.231 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.892834e-03 | 2.230 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.019767e-03 | 2.220 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.104181e-03 | 2.214 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.104181e-03 | 2.214 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.104181e-03 | 2.214 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.104181e-03 | 2.214 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.886930e-03 | 2.162 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.071456e-03 | 2.150 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.192446e-03 | 2.143 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.209911e-03 | 2.142 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.337532e-03 | 2.134 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.337532e-03 | 2.134 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.337532e-03 | 2.134 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.753842e-03 | 2.110 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.756499e-03 | 2.110 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 8.258359e-03 | 2.083 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.258359e-03 | 2.083 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.680626e-03 | 2.061 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.941752e-03 | 2.049 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.091522e-03 | 2.041 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 9.101277e-03 | 2.041 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.208132e-03 | 2.036 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.413117e-03 | 2.026 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 9.996238e-03 | 2.000 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 9.996238e-03 | 2.000 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 9.996238e-03 | 2.000 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.192482e-02 | 1.924 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.178249e-02 | 1.929 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.178249e-02 | 1.929 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.138725e-02 | 1.944 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.178249e-02 | 1.929 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.192482e-02 | 1.924 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.178249e-02 | 1.929 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.261164e-02 | 1.899 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.192482e-02 | 1.924 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.158708e-02 | 1.936 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.265206e-02 | 1.898 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.319910e-02 | 1.879 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.332864e-02 | 1.875 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.414400e-02 | 1.849 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.416464e-02 | 1.849 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.438974e-02 | 1.842 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.438974e-02 | 1.842 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.438974e-02 | 1.842 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.478647e-02 | 1.830 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.497645e-02 | 1.825 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.497645e-02 | 1.825 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.499616e-02 | 1.824 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.532096e-02 | 1.815 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.533938e-02 | 1.814 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.590657e-02 | 1.798 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.590657e-02 | 1.798 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.604061e-02 | 1.795 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.610002e-02 | 1.793 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.610002e-02 | 1.793 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.627537e-02 | 1.788 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.642807e-02 | 1.784 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.661185e-02 | 1.780 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.704415e-02 | 1.768 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.711255e-02 | 1.767 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.753853e-02 | 1.756 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.753853e-02 | 1.756 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.753853e-02 | 1.756 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.766047e-02 | 1.753 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.766047e-02 | 1.753 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.849637e-02 | 1.733 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.849637e-02 | 1.733 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.849637e-02 | 1.733 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.849637e-02 | 1.733 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.849637e-02 | 1.733 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.849637e-02 | 1.733 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.867487e-02 | 1.729 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.872603e-02 | 1.728 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.872603e-02 | 1.728 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.872603e-02 | 1.728 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.913296e-02 | 1.718 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.926511e-02 | 1.715 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.937281e-02 | 1.713 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.965566e-02 | 1.707 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.965566e-02 | 1.707 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.998856e-02 | 1.699 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.998856e-02 | 1.699 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.488092e-02 | 1.604 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.081867e-02 | 1.682 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.081867e-02 | 1.682 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.068747e-02 | 1.684 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.631967e-02 | 1.580 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.286778e-02 | 1.641 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.168336e-02 | 1.664 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.494284e-02 | 1.603 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.494284e-02 | 1.603 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.390756e-02 | 1.621 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.347429e-02 | 1.629 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.134929e-02 | 1.671 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.662394e-02 | 1.575 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.488092e-02 | 1.604 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.488092e-02 | 1.604 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.617240e-02 | 1.582 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.306343e-02 | 1.637 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.306343e-02 | 1.637 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.161345e-02 | 1.665 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.660191e-02 | 1.575 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.168336e-02 | 1.664 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.384016e-02 | 1.623 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.293059e-02 | 1.640 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.384016e-02 | 1.623 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.384016e-02 | 1.623 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.349769e-02 | 1.629 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.083195e-02 | 1.681 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.675908e-02 | 1.573 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.675908e-02 | 1.573 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.675908e-02 | 1.573 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.675908e-02 | 1.573 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.631967e-02 | 1.580 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.631967e-02 | 1.580 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.252061e-02 | 1.647 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.675908e-02 | 1.573 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.382548e-02 | 1.623 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.534724e-02 | 1.596 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.780477e-02 | 1.556 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.782736e-02 | 1.556 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.804433e-02 | 1.552 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.804433e-02 | 1.552 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.816602e-02 | 1.550 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.816602e-02 | 1.550 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.816602e-02 | 1.550 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.819457e-02 | 1.550 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.853550e-02 | 1.545 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.853550e-02 | 1.545 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.853550e-02 | 1.545 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.853550e-02 | 1.545 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.864288e-02 | 1.543 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.078834e-02 | 1.512 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.078834e-02 | 1.512 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.080193e-02 | 1.511 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.093731e-02 | 1.510 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.138481e-02 | 1.503 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.138481e-02 | 1.503 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.266799e-02 | 1.486 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.267580e-02 | 1.486 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.315212e-02 | 1.479 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.326882e-02 | 1.478 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.367780e-02 | 1.473 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.410778e-02 | 1.467 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.474573e-02 | 1.459 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.537827e-02 | 1.451 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.537827e-02 | 1.451 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.578023e-02 | 1.446 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.578023e-02 | 1.446 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.661725e-02 | 1.436 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.661725e-02 | 1.436 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.677826e-02 | 1.434 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.687458e-02 | 1.433 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.687458e-02 | 1.433 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.687458e-02 | 1.433 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.687458e-02 | 1.433 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.693578e-02 | 1.433 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.729774e-02 | 1.428 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.804004e-02 | 1.420 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.805446e-02 | 1.420 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.891703e-02 | 1.410 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.891703e-02 | 1.410 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.999552e-02 | 1.398 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.999552e-02 | 1.398 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.029532e-02 | 1.395 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.040917e-02 | 1.394 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.040917e-02 | 1.394 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.145442e-02 | 1.382 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.301209e-02 | 1.366 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.492793e-02 | 1.347 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.084670e-02 | 1.294 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.084670e-02 | 1.294 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.696463e-02 | 1.328 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.696463e-02 | 1.328 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.843263e-02 | 1.233 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.869070e-02 | 1.313 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.869070e-02 | 1.313 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.869070e-02 | 1.313 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.804122e-02 | 1.236 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.834648e-02 | 1.165 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.834648e-02 | 1.165 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.834648e-02 | 1.165 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.475493e-02 | 1.262 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.321803e-02 | 1.199 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.517876e-02 | 1.186 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.007277e-02 | 1.300 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.007277e-02 | 1.300 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.044449e-02 | 1.297 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.517876e-02 | 1.186 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.782982e-02 | 1.238 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.804122e-02 | 1.236 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.627774e-02 | 1.335 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.827133e-02 | 1.235 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.184549e-02 | 1.285 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.869070e-02 | 1.313 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.517876e-02 | 1.186 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.987834e-02 | 1.302 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.817266e-02 | 1.235 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.927318e-02 | 1.227 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.234215e-02 | 1.205 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.044449e-02 | 1.297 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.669089e-02 | 1.331 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.409738e-02 | 1.193 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.970025e-02 | 1.224 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.627774e-02 | 1.335 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.627774e-02 | 1.335 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.819536e-02 | 1.166 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.830449e-02 | 1.234 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.750162e-02 | 1.240 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.197138e-02 | 1.284 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 4.701671e-02 | 1.328 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.593555e-02 | 1.252 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.409738e-02 | 1.193 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.834648e-02 | 1.165 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.386272e-02 | 1.195 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.386272e-02 | 1.195 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.386272e-02 | 1.195 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.589447e-02 | 1.338 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.473691e-02 | 1.189 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.782982e-02 | 1.238 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.980888e-02 | 1.223 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.609527e-02 | 1.251 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.044449e-02 | 1.297 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.939821e-02 | 1.306 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.827133e-02 | 1.235 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.517876e-02 | 1.186 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.232678e-02 | 1.281 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.874411e-02 | 1.312 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.475493e-02 | 1.262 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.007277e-02 | 1.300 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.475493e-02 | 1.262 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.531232e-02 | 1.257 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.321803e-02 | 1.199 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.517876e-02 | 1.186 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.927318e-02 | 1.227 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.184549e-02 | 1.285 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.921501e-02 | 1.228 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.997585e-02 | 1.155 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.077884e-02 | 1.150 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.125360e-02 | 1.147 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.155913e-02 | 1.145 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.155913e-02 | 1.145 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.257222e-02 | 1.139 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.257222e-02 | 1.139 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.257222e-02 | 1.139 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.257222e-02 | 1.139 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.311789e-02 | 1.136 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.336158e-02 | 1.135 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.537875e-02 | 1.123 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.552056e-02 | 1.122 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.639027e-02 | 1.117 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.684684e-02 | 1.114 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.713211e-02 | 1.113 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.959629e-02 | 1.099 | 1 | 1 |
| Glycogen storage diseases | R-HSA-3229121 | 7.959629e-02 | 1.099 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.045376e-02 | 1.094 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.145881e-02 | 1.089 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.538377e-02 | 1.069 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.538377e-02 | 1.069 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.538377e-02 | 1.069 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.538377e-02 | 1.069 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.539422e-02 | 1.069 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 8.577285e-02 | 1.067 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.624883e-02 | 1.064 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.882306e-02 | 1.051 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.882306e-02 | 1.051 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.953291e-02 | 1.048 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.155600e-02 | 1.038 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.155600e-02 | 1.038 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.177130e-02 | 1.037 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.177130e-02 | 1.037 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 9.177130e-02 | 1.037 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 9.177130e-02 | 1.037 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.210297e-02 | 1.036 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.279857e-02 | 1.032 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 9.295096e-02 | 1.032 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.295096e-02 | 1.032 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 9.295096e-02 | 1.032 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 9.295096e-02 | 1.032 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.316476e-02 | 1.031 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.332923e-02 | 1.030 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.332923e-02 | 1.030 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.377340e-02 | 1.028 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.377340e-02 | 1.028 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.377340e-02 | 1.028 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.470523e-02 | 1.024 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.470523e-02 | 1.024 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.470523e-02 | 1.024 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 9.470523e-02 | 1.024 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.630702e-02 | 1.016 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.784179e-02 | 1.009 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.816422e-02 | 1.008 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.817149e-02 | 1.008 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.912948e-02 | 1.004 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.007633e-01 | 0.997 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.016803e-01 | 0.993 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.016803e-01 | 0.993 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.016803e-01 | 0.993 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.016969e-01 | 0.993 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.041945e-01 | 0.982 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.041945e-01 | 0.982 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.042373e-01 | 0.982 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.042810e-01 | 0.982 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.042810e-01 | 0.982 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.042810e-01 | 0.982 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.048438e-01 | 0.979 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.048438e-01 | 0.979 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.052284e-01 | 0.978 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.056351e-01 | 0.976 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.056351e-01 | 0.976 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.061708e-01 | 0.974 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.061708e-01 | 0.974 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.061708e-01 | 0.974 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.062855e-01 | 0.974 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.104438e-01 | 0.957 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.104438e-01 | 0.957 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.120451e-01 | 0.951 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.120451e-01 | 0.951 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.125970e-01 | 0.948 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.133313e-01 | 0.946 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.162938e-01 | 0.934 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.168192e-01 | 0.932 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.173188e-01 | 0.931 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.187785e-01 | 0.925 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.187785e-01 | 0.925 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.187785e-01 | 0.925 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.187785e-01 | 0.925 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.187785e-01 | 0.925 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.187785e-01 | 0.925 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 1.187785e-01 | 0.925 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.194772e-01 | 0.923 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.205796e-01 | 0.919 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.210498e-01 | 0.917 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.210498e-01 | 0.917 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.215245e-01 | 0.915 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.215245e-01 | 0.915 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.228607e-01 | 0.911 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.265963e-01 | 0.898 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.270899e-01 | 0.896 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.270899e-01 | 0.896 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.270899e-01 | 0.896 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.277641e-01 | 0.894 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.277641e-01 | 0.894 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.277641e-01 | 0.894 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.277641e-01 | 0.894 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.277641e-01 | 0.894 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.282480e-01 | 0.892 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.282480e-01 | 0.892 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.282480e-01 | 0.892 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.282480e-01 | 0.892 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 1.282480e-01 | 0.892 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.282480e-01 | 0.892 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.282480e-01 | 0.892 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.282480e-01 | 0.892 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.289662e-01 | 0.890 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.289662e-01 | 0.890 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.289662e-01 | 0.890 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.299435e-01 | 0.886 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.300084e-01 | 0.886 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.300084e-01 | 0.886 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.335335e-01 | 0.874 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.335335e-01 | 0.874 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.346881e-01 | 0.871 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.347377e-01 | 0.871 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.349664e-01 | 0.870 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.349664e-01 | 0.870 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.349664e-01 | 0.870 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.374619e-01 | 0.862 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.861158e-01 | 0.730 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.861158e-01 | 0.730 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.861158e-01 | 0.730 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.861158e-01 | 0.730 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 1.861158e-01 | 0.730 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.657571e-01 | 0.576 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 2.657571e-01 | 0.576 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.657571e-01 | 0.576 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.657571e-01 | 0.576 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.657571e-01 | 0.576 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.657571e-01 | 0.576 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.657571e-01 | 0.576 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.657571e-01 | 0.576 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.657571e-01 | 0.576 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.657571e-01 | 0.576 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.630225e-01 | 0.788 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.630225e-01 | 0.788 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.630225e-01 | 0.788 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.997344e-01 | 0.700 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.517828e-01 | 0.819 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.517828e-01 | 0.819 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.372783e-01 | 0.625 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.372783e-01 | 0.625 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.372783e-01 | 0.625 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.372783e-01 | 0.625 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.372783e-01 | 0.625 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.765512e-01 | 0.753 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.765512e-01 | 0.753 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.765512e-01 | 0.753 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.765512e-01 | 0.753 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.023324e-01 | 0.694 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.023324e-01 | 0.694 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.751402e-01 | 0.560 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.751402e-01 | 0.560 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.751402e-01 | 0.560 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.751402e-01 | 0.560 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.751402e-01 | 0.560 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.731617e-01 | 0.762 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.731617e-01 | 0.762 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.289131e-01 | 0.640 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.289131e-01 | 0.640 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.289131e-01 | 0.640 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.289131e-01 | 0.640 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.289131e-01 | 0.640 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.289131e-01 | 0.640 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.289131e-01 | 0.640 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.289131e-01 | 0.640 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.289131e-01 | 0.640 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.289131e-01 | 0.640 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.145492e-01 | 0.668 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.561784e-01 | 0.806 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.177950e-01 | 0.662 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.582931e-01 | 0.588 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.582931e-01 | 0.588 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.363328e-01 | 0.626 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.552858e-01 | 0.593 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.712753e-01 | 0.766 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.976726e-01 | 0.704 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.976726e-01 | 0.704 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.745901e-01 | 0.561 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.502043e-01 | 0.602 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.107650e-01 | 0.676 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.188376e-01 | 0.660 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.443502e-01 | 0.612 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.193864e-01 | 0.659 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.011611e-01 | 0.696 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.606507e-01 | 0.794 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.291840e-01 | 0.640 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.741667e-01 | 0.759 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.826898e-01 | 0.738 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.378990e-01 | 0.624 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.637596e-01 | 0.786 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.706538e-01 | 0.768 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.289131e-01 | 0.640 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.630225e-01 | 0.788 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.630225e-01 | 0.788 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.751402e-01 | 0.560 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.011611e-01 | 0.696 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.361788e-01 | 0.627 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.502043e-01 | 0.602 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.459605e-01 | 0.836 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.289131e-01 | 0.640 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.944326e-01 | 0.711 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.363328e-01 | 0.626 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.736471e-01 | 0.760 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.560902e-01 | 0.592 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.001081e-01 | 0.699 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.574749e-01 | 0.589 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.508005e-01 | 0.822 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.508005e-01 | 0.822 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.720952e-01 | 0.764 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.997344e-01 | 0.700 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.361788e-01 | 0.627 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.378125e-01 | 0.861 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.849267e-01 | 0.733 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.107650e-01 | 0.676 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.241815e-01 | 0.649 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.604566e-01 | 0.584 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.720952e-01 | 0.764 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.442325e-01 | 0.612 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.468688e-01 | 0.833 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.907184e-01 | 0.720 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.997366e-01 | 0.700 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.560902e-01 | 0.592 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.861417e-01 | 0.730 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.672559e-01 | 0.573 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.459191e-01 | 0.836 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.971645e-01 | 0.705 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.971645e-01 | 0.705 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.672559e-01 | 0.573 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.361788e-01 | 0.627 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.130695e-01 | 0.671 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.493625e-01 | 0.826 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.171133e-01 | 0.663 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.818321e-01 | 0.740 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.861158e-01 | 0.730 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.861158e-01 | 0.730 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.657571e-01 | 0.576 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.657571e-01 | 0.576 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.997344e-01 | 0.700 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.023324e-01 | 0.694 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.023324e-01 | 0.694 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.751402e-01 | 0.560 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.997366e-01 | 0.700 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.363328e-01 | 0.626 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.502043e-01 | 0.602 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.502043e-01 | 0.602 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.619202e-01 | 0.582 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.867295e-01 | 0.729 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.626592e-01 | 0.789 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.372059e-01 | 0.625 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.289131e-01 | 0.640 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.490612e-01 | 0.827 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.171133e-01 | 0.663 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.907184e-01 | 0.720 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.468688e-01 | 0.833 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.825914e-01 | 0.739 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.133551e-01 | 0.671 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.751402e-01 | 0.560 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.751402e-01 | 0.560 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.751402e-01 | 0.560 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.517828e-01 | 0.819 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.502043e-01 | 0.602 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.089679e-01 | 0.680 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.798203e-01 | 0.745 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.582931e-01 | 0.588 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.552858e-01 | 0.593 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.536135e-01 | 0.814 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.361788e-01 | 0.627 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.241815e-01 | 0.649 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.188376e-01 | 0.660 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.997344e-01 | 0.700 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.372783e-01 | 0.625 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.661397e-01 | 0.575 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.490612e-01 | 0.827 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.552858e-01 | 0.593 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.517828e-01 | 0.819 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.849267e-01 | 0.733 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.314647e-01 | 0.636 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.602042e-01 | 0.795 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.751402e-01 | 0.560 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.250662e-01 | 0.648 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.552858e-01 | 0.593 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.593268e-01 | 0.586 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.517828e-01 | 0.819 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.935084e-01 | 0.713 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.997344e-01 | 0.700 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.731617e-01 | 0.762 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.154498e-01 | 0.667 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 2.379669e-01 | 0.623 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.544708e-01 | 0.811 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.536135e-01 | 0.814 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.751911e-01 | 0.560 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.751911e-01 | 0.560 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.807899e-01 | 0.552 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.807899e-01 | 0.552 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.836731e-01 | 0.547 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.836731e-01 | 0.547 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 2.836731e-01 | 0.547 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.903944e-01 | 0.537 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.910359e-01 | 0.536 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.941821e-01 | 0.531 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.941821e-01 | 0.531 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.941821e-01 | 0.531 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.941821e-01 | 0.531 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.944182e-01 | 0.531 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.952879e-01 | 0.530 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.998677e-01 | 0.523 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.013259e-01 | 0.521 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.035704e-01 | 0.518 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.035704e-01 | 0.518 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.114851e-01 | 0.507 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.114851e-01 | 0.507 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.114851e-01 | 0.507 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.114851e-01 | 0.507 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.128988e-01 | 0.505 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.128988e-01 | 0.505 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.139991e-01 | 0.503 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.172554e-01 | 0.499 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.199044e-01 | 0.495 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.217268e-01 | 0.493 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.230212e-01 | 0.491 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.232921e-01 | 0.490 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.265395e-01 | 0.486 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.265395e-01 | 0.486 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.353450e-01 | 0.475 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.376094e-01 | 0.472 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.376094e-01 | 0.472 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.376094e-01 | 0.472 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.376094e-01 | 0.472 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.376094e-01 | 0.472 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.376094e-01 | 0.472 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.376094e-01 | 0.472 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.376094e-01 | 0.472 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.376094e-01 | 0.472 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.376094e-01 | 0.472 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.376094e-01 | 0.472 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.376094e-01 | 0.472 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.376094e-01 | 0.472 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.376094e-01 | 0.472 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.376094e-01 | 0.472 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.376094e-01 | 0.472 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.376094e-01 | 0.472 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 3.376094e-01 | 0.472 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.376094e-01 | 0.472 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.376094e-01 | 0.472 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.376094e-01 | 0.472 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.376094e-01 | 0.472 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 3.376094e-01 | 0.472 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.376094e-01 | 0.472 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.376094e-01 | 0.472 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.376094e-01 | 0.472 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.378057e-01 | 0.471 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.378057e-01 | 0.471 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.393644e-01 | 0.469 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.407642e-01 | 0.468 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.496070e-01 | 0.456 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.502120e-01 | 0.456 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.502120e-01 | 0.456 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.502120e-01 | 0.456 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 3.502120e-01 | 0.456 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.502120e-01 | 0.456 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.502120e-01 | 0.456 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.502120e-01 | 0.456 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.502120e-01 | 0.456 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.528367e-01 | 0.452 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.529721e-01 | 0.452 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.536510e-01 | 0.451 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.550543e-01 | 0.450 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.558115e-01 | 0.449 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.558115e-01 | 0.449 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.586995e-01 | 0.445 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.594454e-01 | 0.444 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.671640e-01 | 0.435 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.671640e-01 | 0.435 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.671640e-01 | 0.435 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.671640e-01 | 0.435 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.719273e-01 | 0.430 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.719799e-01 | 0.429 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.722624e-01 | 0.429 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.726033e-01 | 0.429 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.738805e-01 | 0.427 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.741997e-01 | 0.427 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.741997e-01 | 0.427 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.741997e-01 | 0.427 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.741997e-01 | 0.427 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.861293e-01 | 0.413 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.868056e-01 | 0.413 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.868056e-01 | 0.413 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.868056e-01 | 0.413 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.868056e-01 | 0.413 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.868056e-01 | 0.413 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.868056e-01 | 0.413 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 3.868056e-01 | 0.413 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 3.868056e-01 | 0.413 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.868056e-01 | 0.413 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.868056e-01 | 0.413 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.919726e-01 | 0.407 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.934099e-01 | 0.405 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.947522e-01 | 0.404 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.947522e-01 | 0.404 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.947522e-01 | 0.404 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.947522e-01 | 0.404 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.957016e-01 | 0.403 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.957016e-01 | 0.403 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.957016e-01 | 0.403 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.957016e-01 | 0.403 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.957016e-01 | 0.403 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.970290e-01 | 0.401 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.019012e-01 | 0.396 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.024342e-01 | 0.395 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.024342e-01 | 0.395 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.024342e-01 | 0.395 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.024342e-01 | 0.395 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.024342e-01 | 0.395 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.024342e-01 | 0.395 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.024342e-01 | 0.395 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.034936e-01 | 0.394 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.100492e-01 | 0.387 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.100492e-01 | 0.387 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.100492e-01 | 0.387 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.100492e-01 | 0.387 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.100492e-01 | 0.387 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 4.114362e-01 | 0.386 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.126506e-01 | 0.384 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.175623e-01 | 0.379 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.185753e-01 | 0.378 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.185753e-01 | 0.378 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.220121e-01 | 0.375 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.220121e-01 | 0.375 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.220121e-01 | 0.375 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.220121e-01 | 0.375 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.222733e-01 | 0.374 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.224633e-01 | 0.374 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.224633e-01 | 0.374 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.224633e-01 | 0.374 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.224633e-01 | 0.374 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.224633e-01 | 0.374 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.224633e-01 | 0.374 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 4.224633e-01 | 0.374 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.280734e-01 | 0.368 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.412406e-01 | 0.355 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.412406e-01 | 0.355 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 4.412406e-01 | 0.355 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.460100e-01 | 0.351 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.488411e-01 | 0.348 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.488411e-01 | 0.348 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.541673e-01 | 0.343 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.541673e-01 | 0.343 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.541673e-01 | 0.343 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.570179e-01 | 0.340 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.570179e-01 | 0.340 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.570179e-01 | 0.340 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.570179e-01 | 0.340 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.570179e-01 | 0.340 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.570179e-01 | 0.340 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.570179e-01 | 0.340 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.609183e-01 | 0.336 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.609183e-01 | 0.336 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.609183e-01 | 0.336 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.609183e-01 | 0.336 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.609183e-01 | 0.336 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.609183e-01 | 0.336 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.609183e-01 | 0.336 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.609183e-01 | 0.336 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.609183e-01 | 0.336 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.609183e-01 | 0.336 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.636356e-01 | 0.334 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.636356e-01 | 0.334 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.638258e-01 | 0.334 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.647606e-01 | 0.333 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.691862e-01 | 0.329 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.751502e-01 | 0.323 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.751502e-01 | 0.323 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.751502e-01 | 0.323 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.751502e-01 | 0.323 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.857042e-01 | 0.314 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.903439e-01 | 0.309 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.903439e-01 | 0.309 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.903439e-01 | 0.309 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.903439e-01 | 0.309 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.903439e-01 | 0.309 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.903439e-01 | 0.309 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.903439e-01 | 0.309 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.931620e-01 | 0.307 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.989713e-01 | 0.302 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.989713e-01 | 0.302 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.008635e-01 | 0.300 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.008635e-01 | 0.300 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.008635e-01 | 0.300 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.008635e-01 | 0.300 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.073963e-01 | 0.295 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.073963e-01 | 0.295 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.073963e-01 | 0.295 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 5.122409e-01 | 0.291 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.122720e-01 | 0.290 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.122720e-01 | 0.290 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.136817e-01 | 0.289 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.136817e-01 | 0.289 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.136817e-01 | 0.289 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.136817e-01 | 0.289 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.136817e-01 | 0.289 | 0 | 0 |
| Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) | R-HSA-5619067 | 5.136817e-01 | 0.289 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.136817e-01 | 0.289 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.136817e-01 | 0.289 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.136817e-01 | 0.289 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.136817e-01 | 0.289 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.136817e-01 | 0.289 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.136817e-01 | 0.289 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.136817e-01 | 0.289 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.136817e-01 | 0.289 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.136817e-01 | 0.289 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.136817e-01 | 0.289 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.162443e-01 | 0.287 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.223507e-01 | 0.282 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.223507e-01 | 0.282 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.223507e-01 | 0.282 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.223507e-01 | 0.282 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.223507e-01 | 0.282 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.223507e-01 | 0.282 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.223507e-01 | 0.282 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.223507e-01 | 0.282 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.259171e-01 | 0.279 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.259171e-01 | 0.279 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 5.259171e-01 | 0.279 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.259171e-01 | 0.279 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.259171e-01 | 0.279 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 5.259171e-01 | 0.279 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.353361e-01 | 0.271 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.354352e-01 | 0.271 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.494788e-01 | 0.260 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.494788e-01 | 0.260 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.494788e-01 | 0.260 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 5.494788e-01 | 0.260 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.495537e-01 | 0.260 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.500642e-01 | 0.260 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.502581e-01 | 0.259 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.502581e-01 | 0.259 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.502581e-01 | 0.259 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.502581e-01 | 0.259 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.502581e-01 | 0.259 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.508175e-01 | 0.259 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.529775e-01 | 0.257 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.529775e-01 | 0.257 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.529775e-01 | 0.257 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.529775e-01 | 0.257 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.612836e-01 | 0.251 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.612836e-01 | 0.251 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.612836e-01 | 0.251 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.612836e-01 | 0.251 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.612836e-01 | 0.251 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.612836e-01 | 0.251 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.612836e-01 | 0.251 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.612836e-01 | 0.251 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.612836e-01 | 0.251 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.612836e-01 | 0.251 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.612836e-01 | 0.251 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.612836e-01 | 0.251 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.612836e-01 | 0.251 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.612836e-01 | 0.251 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.612836e-01 | 0.251 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.612836e-01 | 0.251 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.612836e-01 | 0.251 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.612836e-01 | 0.251 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.654887e-01 | 0.248 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.676694e-01 | 0.246 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.697967e-01 | 0.244 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.697967e-01 | 0.244 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.697967e-01 | 0.244 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.697967e-01 | 0.244 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.738443e-01 | 0.241 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.738443e-01 | 0.241 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.738443e-01 | 0.241 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 5.738443e-01 | 0.241 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.738443e-01 | 0.241 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.816029e-01 | 0.235 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.821876e-01 | 0.235 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.821876e-01 | 0.235 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.821876e-01 | 0.235 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.821876e-01 | 0.235 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.854029e-01 | 0.233 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.900510e-01 | 0.229 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.902327e-01 | 0.229 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.924366e-01 | 0.227 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.938505e-01 | 0.226 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.966425e-01 | 0.224 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.966425e-01 | 0.224 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.966425e-01 | 0.224 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.966425e-01 | 0.224 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.042287e-01 | 0.219 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.042287e-01 | 0.219 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.042287e-01 | 0.219 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.042287e-01 | 0.219 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.042287e-01 | 0.219 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.042287e-01 | 0.219 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.042287e-01 | 0.219 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.042287e-01 | 0.219 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.042287e-01 | 0.219 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.042287e-01 | 0.219 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.042287e-01 | 0.219 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 6.042287e-01 | 0.219 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.042287e-01 | 0.219 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.042287e-01 | 0.219 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.042287e-01 | 0.219 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.042287e-01 | 0.219 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.042287e-01 | 0.219 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.074576e-01 | 0.216 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.088427e-01 | 0.215 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.088427e-01 | 0.215 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.099651e-01 | 0.215 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.099651e-01 | 0.215 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.099651e-01 | 0.215 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.099651e-01 | 0.215 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.099651e-01 | 0.215 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.099651e-01 | 0.215 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.099651e-01 | 0.215 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.099651e-01 | 0.215 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.099651e-01 | 0.215 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.099651e-01 | 0.215 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.118156e-01 | 0.213 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.186284e-01 | 0.209 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.186284e-01 | 0.209 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.186284e-01 | 0.209 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.186284e-01 | 0.209 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.196446e-01 | 0.208 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.275277e-01 | 0.202 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.361206e-01 | 0.196 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.361206e-01 | 0.196 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.361206e-01 | 0.196 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.363104e-01 | 0.196 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.363104e-01 | 0.196 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.363104e-01 | 0.196 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.397853e-01 | 0.194 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.397853e-01 | 0.194 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.429722e-01 | 0.192 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.429722e-01 | 0.192 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.429722e-01 | 0.192 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.429722e-01 | 0.192 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.429722e-01 | 0.192 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.429722e-01 | 0.192 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.429722e-01 | 0.192 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.429722e-01 | 0.192 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.429722e-01 | 0.192 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.429722e-01 | 0.192 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.429722e-01 | 0.192 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.456326e-01 | 0.190 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.456326e-01 | 0.190 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.456326e-01 | 0.190 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.456326e-01 | 0.190 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.505325e-01 | 0.187 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.520533e-01 | 0.186 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.521494e-01 | 0.186 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.521494e-01 | 0.186 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.587917e-01 | 0.181 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.601031e-01 | 0.180 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.601031e-01 | 0.180 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.601031e-01 | 0.180 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.612378e-01 | 0.180 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.612378e-01 | 0.180 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.612378e-01 | 0.180 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.612378e-01 | 0.180 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.653540e-01 | 0.177 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.653540e-01 | 0.177 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.656203e-01 | 0.177 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.747522e-01 | 0.171 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.779251e-01 | 0.169 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.779251e-01 | 0.169 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.779251e-01 | 0.169 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.779251e-01 | 0.169 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.779251e-01 | 0.169 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.779251e-01 | 0.169 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.779251e-01 | 0.169 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.779251e-01 | 0.169 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.779251e-01 | 0.169 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.779251e-01 | 0.169 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.779251e-01 | 0.169 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.779251e-01 | 0.169 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.779251e-01 | 0.169 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.779251e-01 | 0.169 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.779251e-01 | 0.169 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.779251e-01 | 0.169 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.779251e-01 | 0.169 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.779251e-01 | 0.169 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.795781e-01 | 0.168 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.795781e-01 | 0.168 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.795781e-01 | 0.168 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.795781e-01 | 0.168 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.795781e-01 | 0.168 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.800605e-01 | 0.167 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.800605e-01 | 0.167 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.808307e-01 | 0.167 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.809611e-01 | 0.167 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.828292e-01 | 0.166 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.828292e-01 | 0.166 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.828292e-01 | 0.166 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.828292e-01 | 0.166 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.838131e-01 | 0.165 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.839651e-01 | 0.165 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.847723e-01 | 0.164 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.847723e-01 | 0.164 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.847723e-01 | 0.164 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.847723e-01 | 0.164 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.847723e-01 | 0.164 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.847723e-01 | 0.164 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.848243e-01 | 0.164 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.939997e-01 | 0.159 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.955924e-01 | 0.158 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.963715e-01 | 0.157 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 6.963715e-01 | 0.157 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.963715e-01 | 0.157 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.982119e-01 | 0.156 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.982119e-01 | 0.156 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.982119e-01 | 0.156 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.982119e-01 | 0.156 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 6.982119e-01 | 0.156 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.069477e-01 | 0.151 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.069477e-01 | 0.151 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.069477e-01 | 0.151 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.094579e-01 | 0.149 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.094579e-01 | 0.149 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.094579e-01 | 0.149 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.094579e-01 | 0.149 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.094579e-01 | 0.149 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.094579e-01 | 0.149 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.094579e-01 | 0.149 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.094579e-01 | 0.149 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.094579e-01 | 0.149 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.094579e-01 | 0.149 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.120778e-01 | 0.147 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.120778e-01 | 0.147 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.120778e-01 | 0.147 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.120778e-01 | 0.147 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.120778e-01 | 0.147 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.120778e-01 | 0.147 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.120778e-01 | 0.147 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.129847e-01 | 0.147 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.129847e-01 | 0.147 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.153444e-01 | 0.145 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.160108e-01 | 0.145 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.160108e-01 | 0.145 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.160108e-01 | 0.145 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.160108e-01 | 0.145 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.160108e-01 | 0.145 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.182967e-01 | 0.144 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.255642e-01 | 0.139 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 7.271807e-01 | 0.138 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.276213e-01 | 0.138 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.278045e-01 | 0.138 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.278045e-01 | 0.138 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.319880e-01 | 0.135 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.329851e-01 | 0.135 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.379052e-01 | 0.132 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.379052e-01 | 0.132 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.379052e-01 | 0.132 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.379052e-01 | 0.132 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.379052e-01 | 0.132 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.398459e-01 | 0.131 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.416839e-01 | 0.130 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.416839e-01 | 0.130 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.416839e-01 | 0.130 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.416839e-01 | 0.130 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.419006e-01 | 0.130 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.460230e-01 | 0.127 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.473883e-01 | 0.126 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.473883e-01 | 0.126 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.473883e-01 | 0.126 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.473883e-01 | 0.126 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.473883e-01 | 0.126 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.473883e-01 | 0.126 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.482171e-01 | 0.126 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.493687e-01 | 0.125 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.493687e-01 | 0.125 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.495494e-01 | 0.125 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.495494e-01 | 0.125 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.498795e-01 | 0.125 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.512863e-01 | 0.124 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.589716e-01 | 0.120 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.609567e-01 | 0.119 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.635687e-01 | 0.117 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.635687e-01 | 0.117 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.635687e-01 | 0.117 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.635687e-01 | 0.117 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.635687e-01 | 0.117 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.635687e-01 | 0.117 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.635687e-01 | 0.117 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.635687e-01 | 0.117 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.645179e-01 | 0.117 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.657483e-01 | 0.116 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.657483e-01 | 0.116 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.657483e-01 | 0.116 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.657483e-01 | 0.116 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.689173e-01 | 0.114 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.703848e-01 | 0.113 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.753755e-01 | 0.110 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.791124e-01 | 0.108 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.791124e-01 | 0.108 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.791124e-01 | 0.108 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 7.791124e-01 | 0.108 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.791124e-01 | 0.108 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.829365e-01 | 0.106 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.829365e-01 | 0.106 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.829365e-01 | 0.106 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.829365e-01 | 0.106 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.829365e-01 | 0.106 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.829365e-01 | 0.106 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.829365e-01 | 0.106 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.867207e-01 | 0.104 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.867207e-01 | 0.104 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.867207e-01 | 0.104 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.867207e-01 | 0.104 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.867207e-01 | 0.104 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.867207e-01 | 0.104 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.867207e-01 | 0.104 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.867300e-01 | 0.104 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.867300e-01 | 0.104 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.882840e-01 | 0.103 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.889493e-01 | 0.103 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.913110e-01 | 0.102 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.929532e-01 | 0.101 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.938475e-01 | 0.100 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.938475e-01 | 0.100 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.990061e-01 | 0.097 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.990061e-01 | 0.097 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.990061e-01 | 0.097 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.990061e-01 | 0.097 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.054771e-01 | 0.094 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.054771e-01 | 0.094 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.054771e-01 | 0.094 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.060632e-01 | 0.094 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.060632e-01 | 0.094 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.076068e-01 | 0.093 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.076068e-01 | 0.093 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.076068e-01 | 0.093 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.076068e-01 | 0.093 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.076068e-01 | 0.093 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.076068e-01 | 0.093 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.076068e-01 | 0.093 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.076068e-01 | 0.093 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.076068e-01 | 0.093 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.076068e-01 | 0.093 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.076621e-01 | 0.093 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.080930e-01 | 0.093 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.127769e-01 | 0.090 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.130271e-01 | 0.090 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.140114e-01 | 0.089 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.140114e-01 | 0.089 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.140114e-01 | 0.089 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.181179e-01 | 0.087 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.184665e-01 | 0.087 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.184665e-01 | 0.087 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.225083e-01 | 0.085 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.264486e-01 | 0.083 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.264486e-01 | 0.083 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.264486e-01 | 0.083 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.264486e-01 | 0.083 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.264486e-01 | 0.083 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.264486e-01 | 0.083 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.264486e-01 | 0.083 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.280066e-01 | 0.082 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.280066e-01 | 0.082 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.280066e-01 | 0.082 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.280066e-01 | 0.082 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.280066e-01 | 0.082 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.280066e-01 | 0.082 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.301881e-01 | 0.081 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.301942e-01 | 0.081 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.369011e-01 | 0.077 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.410458e-01 | 0.075 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.410458e-01 | 0.075 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.410458e-01 | 0.075 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.410458e-01 | 0.075 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.410458e-01 | 0.075 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.412536e-01 | 0.075 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.434462e-01 | 0.074 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.434462e-01 | 0.074 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.434462e-01 | 0.074 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.434462e-01 | 0.074 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.434462e-01 | 0.074 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.434462e-01 | 0.074 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.434462e-01 | 0.074 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.434462e-01 | 0.074 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.434462e-01 | 0.074 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.434462e-01 | 0.074 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.456798e-01 | 0.073 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.456798e-01 | 0.073 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.467474e-01 | 0.072 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.516893e-01 | 0.070 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.531817e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.531817e-01 | 0.069 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.531817e-01 | 0.069 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.531817e-01 | 0.069 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.540642e-01 | 0.069 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.554778e-01 | 0.068 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.558290e-01 | 0.068 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.587800e-01 | 0.066 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.587800e-01 | 0.066 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.587800e-01 | 0.066 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.587800e-01 | 0.066 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.587800e-01 | 0.066 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.587800e-01 | 0.066 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.587800e-01 | 0.066 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.587800e-01 | 0.066 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.587800e-01 | 0.066 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.587800e-01 | 0.066 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.587800e-01 | 0.066 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.587800e-01 | 0.066 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.587800e-01 | 0.066 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.615212e-01 | 0.065 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.644485e-01 | 0.063 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.644663e-01 | 0.063 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.644663e-01 | 0.063 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.726127e-01 | 0.059 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.726127e-01 | 0.059 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.726127e-01 | 0.059 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.726127e-01 | 0.059 | 0 | 0 |
| Mitochondrial Uncoupling | R-HSA-166187 | 8.726127e-01 | 0.059 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.726127e-01 | 0.059 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.726127e-01 | 0.059 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.726222e-01 | 0.059 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.749497e-01 | 0.058 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.749497e-01 | 0.058 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.838869e-01 | 0.054 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.846808e-01 | 0.053 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.846808e-01 | 0.053 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.846808e-01 | 0.053 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 8.850912e-01 | 0.053 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.850912e-01 | 0.053 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.850912e-01 | 0.053 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.850912e-01 | 0.053 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.850912e-01 | 0.053 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.850912e-01 | 0.053 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.850912e-01 | 0.053 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.850912e-01 | 0.053 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.850912e-01 | 0.053 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.850912e-01 | 0.053 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.850912e-01 | 0.053 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.876573e-01 | 0.052 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.876573e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.937061e-01 | 0.049 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.937061e-01 | 0.049 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.939507e-01 | 0.049 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.941067e-01 | 0.049 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.963481e-01 | 0.048 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.963481e-01 | 0.048 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.963481e-01 | 0.048 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.020706e-01 | 0.045 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.065027e-01 | 0.043 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.065027e-01 | 0.043 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.065027e-01 | 0.043 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.065027e-01 | 0.043 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.065027e-01 | 0.043 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.065027e-01 | 0.043 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.065027e-01 | 0.043 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.073870e-01 | 0.042 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.132339e-01 | 0.039 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.132339e-01 | 0.039 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.136895e-01 | 0.039 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.156631e-01 | 0.038 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.156631e-01 | 0.038 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.156631e-01 | 0.038 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.156631e-01 | 0.038 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.156631e-01 | 0.038 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.156631e-01 | 0.038 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.169864e-01 | 0.038 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.169864e-01 | 0.038 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.187493e-01 | 0.037 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.187493e-01 | 0.037 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.187712e-01 | 0.037 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.203336e-01 | 0.036 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.236171e-01 | 0.035 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.239265e-01 | 0.034 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.239265e-01 | 0.034 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.239265e-01 | 0.034 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.239265e-01 | 0.034 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.239486e-01 | 0.034 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.243308e-01 | 0.034 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.276473e-01 | 0.033 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.288467e-01 | 0.032 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.313806e-01 | 0.031 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.313806e-01 | 0.031 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.313806e-01 | 0.031 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.344644e-01 | 0.029 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.352783e-01 | 0.029 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.354076e-01 | 0.029 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.365472e-01 | 0.028 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.370866e-01 | 0.028 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.381048e-01 | 0.028 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.404292e-01 | 0.027 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.406347e-01 | 0.027 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.430798e-01 | 0.025 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.440553e-01 | 0.025 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.441704e-01 | 0.025 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.441704e-01 | 0.025 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.441704e-01 | 0.025 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.441704e-01 | 0.025 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.441704e-01 | 0.025 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.454581e-01 | 0.024 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.457118e-01 | 0.024 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.458154e-01 | 0.024 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.493135e-01 | 0.023 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.496419e-01 | 0.022 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.496419e-01 | 0.022 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.496419e-01 | 0.022 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.496419e-01 | 0.022 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.496419e-01 | 0.022 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.501919e-01 | 0.022 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.501919e-01 | 0.022 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.540075e-01 | 0.020 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.540075e-01 | 0.020 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.545774e-01 | 0.020 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.590295e-01 | 0.018 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.590295e-01 | 0.018 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.590295e-01 | 0.018 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.612660e-01 | 0.017 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.629504e-01 | 0.016 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.630455e-01 | 0.016 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.630455e-01 | 0.016 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.630455e-01 | 0.016 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.630455e-01 | 0.016 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.633020e-01 | 0.016 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.666680e-01 | 0.015 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.666680e-01 | 0.015 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.666680e-01 | 0.015 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.666974e-01 | 0.015 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.675999e-01 | 0.014 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.699356e-01 | 0.013 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.699356e-01 | 0.013 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.701294e-01 | 0.013 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.706312e-01 | 0.013 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.723101e-01 | 0.012 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.728831e-01 | 0.012 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.755418e-01 | 0.011 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.767447e-01 | 0.010 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.767447e-01 | 0.010 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.779399e-01 | 0.010 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.806009e-01 | 0.009 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.807305e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.818931e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.818931e-01 | 0.008 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.820541e-01 | 0.008 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.820541e-01 | 0.008 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.838140e-01 | 0.007 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.850447e-01 | 0.007 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.851800e-01 | 0.006 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.854014e-01 | 0.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.854014e-01 | 0.006 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.862201e-01 | 0.006 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.862201e-01 | 0.006 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.864872e-01 | 0.006 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.867283e-01 | 0.006 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.868219e-01 | 0.006 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.877603e-01 | 0.005 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.880529e-01 | 0.005 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.881247e-01 | 0.005 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.881247e-01 | 0.005 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.886986e-01 | 0.005 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.892896e-01 | 0.005 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.892896e-01 | 0.005 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.892896e-01 | 0.005 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.899983e-01 | 0.004 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.905554e-01 | 0.004 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.911769e-01 | 0.004 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.911874e-01 | 0.004 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.911874e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.911874e-01 | 0.004 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.912879e-01 | 0.004 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.917237e-01 | 0.004 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.921131e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.921426e-01 | 0.003 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.927946e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.927946e-01 | 0.003 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.929135e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.929135e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.936088e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.936496e-01 | 0.003 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.937964e-01 | 0.003 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.938591e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.944975e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.944975e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.946919e-01 | 0.002 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.948194e-01 | 0.002 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.952435e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.953118e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.953118e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.953118e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.956868e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.957719e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.965239e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.965611e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.968443e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.970305e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.972031e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.973618e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.976817e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.977253e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.977253e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.977253e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.978063e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.983564e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.986024e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.986201e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.986201e-01 | 0.001 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.986433e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.988120e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.991910e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.991910e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.993421e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.993421e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.994068e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.995650e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.995650e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996078e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.996464e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.996811e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.996811e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.996968e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.997124e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997407e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.997892e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.997892e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.998031e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998086e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998561e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998595e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.998606e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999025e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999186e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999260e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999544e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999586e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999614e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999701e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999703e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999717e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999842e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999855e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999871e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999876e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999888e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999917e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999923e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999931e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999938e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999963e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999963e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999965e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999984e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999987e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999989e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999993e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999993e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999993e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999997e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999997e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999998e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999998e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |